(881010, 'HP:0034304', 'Epsilon wave', 'MP:0020002', 'increased response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881011, 'HP:0034304', 'Epsilon wave', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881012, 'HP:0034304', 'Epsilon wave', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881013, 'HP:0034304', 'Epsilon wave', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881014, 'HP:0034304', 'Epsilon wave', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881015, 'HP:0034304', 'Epsilon wave', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881016, 'HP:0034304', 'Epsilon wave', 'MP:0000231', 'hypertension', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881017, 'HP:0034304', 'Epsilon wave', 'MP:0006054', 'spinal hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881018, 'HP:0034304', 'Epsilon wave', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881019, 'HP:0034304', 'Epsilon wave', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881020, 'HP:0034304', 'Epsilon wave', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881021, 'HP:0034304', 'Epsilon wave', 'MP:0006052', 'cerebellum hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881022, 'HP:0034304', 'Epsilon wave', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881023, 'HP:0034304', 'Epsilon wave', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881024, 'HP:0034304', 'Epsilon wave', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881025, 'HP:0034304', 'Epsilon wave', 'MP:0012558', 'increased calcium uptake by cardiac muscle', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881026, 'HP:0034304', 'Epsilon wave', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881027, 'HP:0034304', 'Epsilon wave', 'MP:0031130', 'right-to-left shunt', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881028, 'HP:0034304', 'Epsilon wave', 'MP:0003548', 'pulmonary hypertension', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881029, 'HP:0034304', 'Epsilon wave', 'MP:0001876', 'decreased inflammatory response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881030, 'HP:0034304', 'Epsilon wave', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881031, 'HP:0034304', 'Epsilon wave', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881032, 'HP:0034304', 'Epsilon wave', 'MP:0004217', 'salt-sensitive hypertension', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881033, 'HP:0034304', 'Epsilon wave', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881034, 'HP:0034304', 'Epsilon wave', 'MP:0010516', 'absent Q wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881035, 'HP:0034304', 'Epsilon wave', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881036, 'HP:0034304', 'Epsilon wave', 'MP:0010571', 'shortened ST segment', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881037, 'HP:0034304', 'Epsilon wave', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881038, 'HP:0034304', 'Epsilon wave', 'MP:0010758', 'increased right ventricle systolic pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881039, 'HP:0034304', 'Epsilon wave', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881040, 'HP:0034304', 'Epsilon wave', 'MP:0001793', 'abnormal susceptibility to infection', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881041, 'HP:0034304', 'Epsilon wave', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881042, 'HP:0034304', 'Epsilon wave', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881043, 'HP:0034304', 'Epsilon wave', 'MP:0001599', 'abnormal blood volume', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881044, 'HP:0034304', 'Epsilon wave', 'MP:0010504', 'abnormal RR interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881045, 'HP:0034304', 'Epsilon wave', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881046, 'HP:0034304', 'Epsilon wave', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881047, 'HP:0034304', 'Epsilon wave', 'MP:0009698', 'heart hemorrhage', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881048, 'HP:0034304', 'Epsilon wave', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881049, 'HP:0034304', 'Epsilon wave', 'MP:0011925', 'abnormal heart echocardiography feature', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881050, 'HP:0034304', 'Epsilon wave', 'MP:0001627', 'abnormal cardiac output', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881051, 'HP:0034304', 'Epsilon wave', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881052, 'HP:0034304', 'Epsilon wave', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881053, 'HP:0034304', 'Epsilon wave', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881054, 'HP:0034304', 'Epsilon wave', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881055, 'HP:0034304', 'Epsilon wave', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881056, 'HP:0034304', 'Epsilon wave', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881057, 'HP:0034304', 'Epsilon wave', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881058, 'HP:0034304', 'Epsilon wave', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881059, 'HP:0034304', 'Epsilon wave', 'MP:0004072', 'abnormal frontal plane axis', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881060, 'HP:0034304', 'Epsilon wave', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881061, 'HP:0034304', 'Epsilon wave', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881062, 'HP:0034304', 'Epsilon wave', 'MP:0003039', 'increased time of peak ischemic contracture', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881063, 'HP:0034304', 'Epsilon wave', 'MP:0010634', 'increased QRS amplitude', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881064, 'HP:0034304', 'Epsilon wave', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881065, 'HP:0034304', 'Epsilon wave', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881066, 'HP:0034304', 'Epsilon wave', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881067, 'HP:0034304', 'Epsilon wave', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881068, 'HP:0034304', 'Epsilon wave', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881069, 'HP:0034304', 'Epsilon wave', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881070, 'HP:0034304', 'Epsilon wave', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881071, 'HP:0034304', 'Epsilon wave', 'MP:0004071', 'prolonged P wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881072, 'HP:0034304', 'Epsilon wave', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881073, 'HP:0034304', 'Epsilon wave', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881074, 'HP:0034304', 'Epsilon wave', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881075, 'HP:0034304', 'Epsilon wave', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881076, 'HP:0034304', 'Epsilon wave', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881077, 'HP:0034304', 'Epsilon wave', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881078, 'HP:0034304', 'Epsilon wave', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881079, 'HP:0034304', 'Epsilon wave', 'MP:0013135', 'poor circulation in tail', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881080, 'HP:0034304', 'Epsilon wave', 'MP:0010552', 'abnormal HV interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881081, 'HP:0034304', 'Epsilon wave', 'MP:0004484', 'abnormal response of heart to induced stress', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881082, 'HP:0034304', 'Epsilon wave', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881083, 'HP:0034304', 'Epsilon wave', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881084, 'HP:0034304', 'Epsilon wave', 'MP:0020418', 'increased cardiac muscle relaxation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881085, 'HP:0034304', 'Epsilon wave', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881086, 'HP:0034304', 'Epsilon wave', 'MP:0011951', 'increased cardiac stroke volume', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881087, 'HP:0034304', 'Epsilon wave', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881088, 'HP:0034304', 'Epsilon wave', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881089, 'HP:0034304', 'Epsilon wave', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881090, 'HP:0034304', 'Epsilon wave', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881091, 'HP:0034304', 'Epsilon wave', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881092, 'HP:0034304', 'Epsilon wave', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881093, 'HP:0034304', 'Epsilon wave', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881094, 'HP:0034304', 'Epsilon wave', 'MP:0011954', 'shortened PQ interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881095, 'HP:0034304', 'Epsilon wave', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881096, 'HP:0034304', 'Epsilon wave', 'MP:0002419', 'abnormal innate immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881097, 'HP:0034304', 'Epsilon wave', 'MP:0001629', 'abnormal heart rate', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881098, 'HP:0034304', 'Epsilon wave', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881099, 'HP:0034304', 'Epsilon wave', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881100, 'HP:0034304', 'Epsilon wave', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881101, 'HP:0034304', 'Epsilon wave', 'MP:0008555', 'abnormal interferon secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881102, 'HP:0034304', 'Epsilon wave', 'MP:0011930', 'abnormal tricuspid valve flow', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881103, 'HP:0034304', 'Epsilon wave', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881104, 'HP:0034304', 'Epsilon wave', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881105, 'HP:0034304', 'Epsilon wave', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881106, 'HP:0034304', 'Epsilon wave', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881107, 'HP:0034304', 'Epsilon wave', 'MP:0010393', 'shortened QRS complex duration', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881108, 'HP:0034304', 'Epsilon wave', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881109, 'HP:0034304', 'Epsilon wave', 'MP:0005140', 'decreased cardiac muscle contractility', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881110, 'HP:0034304', 'Epsilon wave', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881111, 'HP:0034304', 'Epsilon wave', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881112, 'HP:0034304', 'Epsilon wave', 'MP:0004011', 'decreased diastolic filling velocity', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881113, 'HP:0034304', 'Epsilon wave', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881114, 'HP:0034304', 'Epsilon wave', 'MP:0002420', 'abnormal adaptive immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881115, 'HP:0034304', 'Epsilon wave', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881116, 'HP:0034304', 'Epsilon wave', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881117, 'HP:0034304', 'Epsilon wave', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881118, 'HP:0034304', 'Epsilon wave', 'MP:0003762', 'abnormal immune organ physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881119, 'HP:0034304', 'Epsilon wave', 'MP:0002498', 'abnormal acute inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881120, 'HP:0034304', 'Epsilon wave', 'MP:0020347', 'abnormal myocardial fiber sodium currents', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881121, 'HP:0034304', 'Epsilon wave', 'MP:0004120', 'cardiac ischemia', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881122, 'HP:0034304', 'Epsilon wave', 'MP:0020097', 'low mean heart rate adaptation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881123, 'HP:0034304', 'Epsilon wave', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881124, 'HP:0034304', 'Epsilon wave', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881125, 'HP:0034304', 'Epsilon wave', 'MP:0008817', 'hematoma', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881126, 'HP:0034304', 'Epsilon wave', 'MP:0001596', 'hypotension', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881127, 'HP:0034304', 'Epsilon wave', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881128, 'HP:0034304', 'Epsilon wave', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881129, 'HP:0034304', 'Epsilon wave', 'MP:0003897', 'abnormal ST segment', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881130, 'HP:0034304', 'Epsilon wave', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881131, 'HP:0034304', 'Epsilon wave', 'MP:0003038', 'decreased myocardial infarct size', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881132, 'HP:0034304', 'Epsilon wave', 'MP:0006112', 'angina', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881133, 'HP:0034304', 'Epsilon wave', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881134, 'HP:0034304', 'Epsilon wave', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881135, 'HP:0034304', 'Epsilon wave', 'MP:0020001', 'decreased response to antigen', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881136, 'HP:0034304', 'Epsilon wave', 'MP:0001636', 'irregular heartbeat', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881137, 'HP:0034304', 'Epsilon wave', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881138, 'HP:0034304', 'Epsilon wave', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881139, 'HP:0034304', 'Epsilon wave', 'MP:0005043', 'defective assembly of class II molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881140, 'HP:0034304', 'Epsilon wave', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881141, 'HP:0034304', 'Epsilon wave', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881142, 'HP:0034304', 'Epsilon wave', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881143, 'HP:0034304', 'Epsilon wave', 'MP:0002421', 'abnormal cell-mediated immunity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881144, 'HP:0034304', 'Epsilon wave', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881145, 'HP:0034304', 'Epsilon wave', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881146, 'HP:0034304', 'Epsilon wave', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881147, 'HP:0034304', 'Epsilon wave', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881148, 'HP:0034304', 'Epsilon wave', 'MP:0006045', 'mitral valve regurgitation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881149, 'HP:0034304', 'Epsilon wave', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881150, 'HP:0034304', 'Epsilon wave', 'MP:0011928', 'abnormal mitral valve flow', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881151, 'HP:0034304', 'Epsilon wave', 'MP:0020154', 'impaired humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881152, 'HP:0034304', 'Epsilon wave', 'MP:0011926', 'abnormal heart valve physiology', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881153, 'HP:0034304', 'Epsilon wave', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881154, 'HP:0034304', 'Epsilon wave', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881155, 'HP:0034304', 'Epsilon wave', 'MP:0006051', 'brainstem hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881156, 'HP:0034304', 'Epsilon wave', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881157, 'HP:0034304', 'Epsilon wave', 'MP:0003777', 'lip inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881158, 'HP:0034304', 'Epsilon wave', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881159, 'HP:0034304', 'Epsilon wave', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881160, 'HP:0034304', 'Epsilon wave', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881161, 'HP:0034304', 'Epsilon wave', 'MP:0020155', 'enhanced humoral immune response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881162, 'HP:0034304', 'Epsilon wave', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881163, 'HP:0034304', 'Epsilon wave', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881164, 'HP:0034304', 'Epsilon wave', 'MP:0003824', 'decreased left ventricle developed pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881165, 'HP:0034304', 'Epsilon wave', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881166, 'HP:0034304', 'Epsilon wave', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881167, 'HP:0034304', 'Epsilon wave', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881168, 'HP:0034304', 'Epsilon wave', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881169, 'HP:0034304', 'Epsilon wave', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881170, 'HP:0034304', 'Epsilon wave', 'MP:0004485', 'increased response of heart to induced stress', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881171, 'HP:0034304', 'Epsilon wave', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881172, 'HP:0034304', 'Epsilon wave', 'MP:0006049', 'semilunar valve regurgitation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881173, 'HP:0034304', 'Epsilon wave', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881174, 'HP:0034304', 'Epsilon wave', 'MP:0011936', 'abnormal PP interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881175, 'HP:0034304', 'Epsilon wave', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881176, 'HP:0034304', 'Epsilon wave', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881177, 'HP:0034304', 'Epsilon wave', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881178, 'HP:0034304', 'Epsilon wave', 'MP:0030132', 'periodontium inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881179, 'HP:0034304', 'Epsilon wave', 'MP:0010515', 'abnormal Q wave', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881180, 'HP:0034304', 'Epsilon wave', 'MP:0005671', 'abnormal response to transplant', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881181, 'HP:0034304', 'Epsilon wave', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881182, 'HP:0034304', 'Epsilon wave', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881183, 'HP:0034304', 'Epsilon wave', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881184, 'HP:0034304', 'Epsilon wave', 'MP:0009732', 'ventricular premature beat', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881185, 'HP:0034304', 'Epsilon wave', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881186, 'HP:0034304', 'Epsilon wave', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881187, 'HP:0034304', 'Epsilon wave', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881188, 'HP:0034304', 'Epsilon wave', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881189, 'HP:0034304', 'Epsilon wave', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881190, 'HP:0034304', 'Epsilon wave', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881191, 'HP:0034304', 'Epsilon wave', 'MP:0010560', 'intraventricular block', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881192, 'HP:0034304', 'Epsilon wave', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881193, 'HP:0034304', 'Epsilon wave', 'MP:0003547', 'abnormal pulmonary pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881194, 'HP:0034304', 'Epsilon wave', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881195, 'HP:0034304', 'Epsilon wave', 'MP:0000465', 'gastrointestinal hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881196, 'HP:0034304', 'Epsilon wave', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881197, 'HP:0034304', 'Epsilon wave', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881198, 'HP:0034304', 'Epsilon wave', 'MP:0010509', 'decreased P wave amplitude', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881199, 'HP:0034304', 'Epsilon wave', 'MP:0010695', 'abnormal blood pressure regulation', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881200, 'HP:0034304', 'Epsilon wave', 'MP:0003549', 'pulmonary hypotension', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881201, 'HP:0034304', 'Epsilon wave', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881202, 'HP:0034304', 'Epsilon wave', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881203, 'HP:0034304', 'Epsilon wave', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881204, 'HP:0034304', 'Epsilon wave', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881205, 'HP:0034304', 'Epsilon wave', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881206, 'HP:0034304', 'Epsilon wave', 'MP:0030153', 'dental pulp inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881207, 'HP:0034304', 'Epsilon wave', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881208, 'HP:0034304', 'Epsilon wave', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881209, 'HP:0034304', 'Epsilon wave', 'MP:0010554', 'shortened HV interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881210, 'HP:0034304', 'Epsilon wave', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881211, 'HP:0034304', 'Epsilon wave', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881212, 'HP:0034304', 'Epsilon wave', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881213, 'HP:0034304', 'Epsilon wave', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881214, 'HP:0034304', 'Epsilon wave', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881215, 'HP:0034304', 'Epsilon wave', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881216, 'HP:0034304', 'Epsilon wave', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881217, 'HP:0034304', 'Epsilon wave', 'MP:0005435', 'hemoperitoneum', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881218, 'HP:0034304', 'Epsilon wave', 'MP:0006265', 'increased pulse pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881219, 'HP:0034304', 'Epsilon wave', 'MP:0011952', 'decreased cardiac stroke volume', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881220, 'HP:0034304', 'Epsilon wave', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881221, 'HP:0034304', 'Epsilon wave', 'MP:0008722', 'abnormal chemokine secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881222, 'HP:0034304', 'Epsilon wave', 'MP:0010631', 'increased Q wave amplitude', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881223, 'HP:0034304', 'Epsilon wave', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881224, 'HP:0034304', 'Epsilon wave', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881225, 'HP:0034304', 'Epsilon wave', 'MP:0012046', 'decreased susceptibility to hypertension', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881226, 'HP:0034304', 'Epsilon wave', 'MP:0000249', 'abnormal blood vessel physiology', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881227, 'HP:0034304', 'Epsilon wave', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881228, 'HP:0034304', 'Epsilon wave', 'MP:0001790', 'abnormal immune system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881229, 'HP:0034304', 'Epsilon wave', 'MP:0010514', 'fragmented QRS complex', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881230, 'HP:0034304', 'Epsilon wave', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881231, 'HP:0034304', 'Epsilon wave', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881232, 'HP:0034304', 'Epsilon wave', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881233, 'HP:0034304', 'Epsilon wave', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881234, 'HP:0034304', 'Epsilon wave', 'MP:0031154', 'intestinal hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881235, 'HP:0034304', 'Epsilon wave', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881236, 'HP:0034304', 'Epsilon wave', 'MP:0003393', 'decreased cardiac output', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881237, 'HP:0034304', 'Epsilon wave', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881238, 'HP:0034304', 'Epsilon wave', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881239, 'HP:0034304', 'Epsilon wave', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881240, 'HP:0034304', 'Epsilon wave', 'MP:0030129', 'tongue inflammation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881241, 'HP:0034304', 'Epsilon wave', 'MP:0002842', 'increased systemic arterial blood pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881242, 'HP:0034304', 'Epsilon wave', 'MP:0003898', 'abnormal QRS complex', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881243, 'HP:0034304', 'Epsilon wave', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881244, 'HP:0034304', 'Epsilon wave', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881245, 'HP:0034304', 'Epsilon wave', 'MP:0005599', 'increased cardiac muscle contractility', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881246, 'HP:0034304', 'Epsilon wave', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881247, 'HP:0034304', 'Epsilon wave', 'MP:0004010', 'increased diastolic filling velocity', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881248, 'HP:0034304', 'Epsilon wave', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881249, 'HP:0034304', 'Epsilon wave', 'MP:0005600', 'increased ventricle muscle contractility', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881250, 'HP:0034304', 'Epsilon wave', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881251, 'HP:0034304', 'Epsilon wave', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881252, 'HP:0034304', 'Epsilon wave', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881253, 'HP:0034304', 'Epsilon wave', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881254, 'HP:0034304', 'Epsilon wave', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881255, 'HP:0034304', 'Epsilon wave', 'MP:0001915', 'intracranial hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881256, 'HP:0034304', 'Epsilon wave', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881257, 'HP:0034304', 'Epsilon wave', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881258, 'HP:0034304', 'Epsilon wave', 'MP:0000304', 'abnormal cardiac stroke volume', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881259, 'HP:0034304', 'Epsilon wave', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881260, 'HP:0034304', 'Epsilon wave', 'MP:0011390', 'abnormal fetal cardiomyocyte physiology', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881261, 'HP:0034304', 'Epsilon wave', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881262, 'HP:0034304', 'Epsilon wave', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881263, 'HP:0034304', 'Epsilon wave', 'MP:0003233', 'prolonged QT interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881264, 'HP:0034304', 'Epsilon wave', 'MP:0002128', 'abnormal blood circulation', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881265, 'HP:0034304', 'Epsilon wave', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881266, 'HP:0034304', 'Epsilon wave', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881267, 'HP:0034304', 'Epsilon wave', 'MP:0009384', 'cardiac valve regurgitation', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881268, 'HP:0034304', 'Epsilon wave', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881269, 'HP:0034304', 'Epsilon wave', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881270, 'HP:0034304', 'Epsilon wave', 'MP:0005598', 'decreased ventricle muscle contractility', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881271, 'HP:0034304', 'Epsilon wave', 'MP:0003394', 'increased cardiac output', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881272, 'HP:0034304', 'Epsilon wave', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881273, 'HP:0034304', 'Epsilon wave', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881274, 'HP:0034304', 'Epsilon wave', 'MP:0005330', 'cardiomyopathy', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881275, 'HP:0034304', 'Epsilon wave', 'MP:0006053', 'hypothalamus hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881276, 'HP:0034304', 'Epsilon wave', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881277, 'HP:0034304', 'Epsilon wave', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881278, 'HP:0034304', 'Epsilon wave', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881279, 'HP:0034304', 'Epsilon wave', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881280, 'HP:0034304', 'Epsilon wave', 'MP:0011938', 'prolonged PP interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881281, 'HP:0034304', 'Epsilon wave', 'MP:0003928', 'increased heart rate variability', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881282, 'HP:0034304', 'Epsilon wave', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881283, 'HP:0034304', 'Epsilon wave', 'MP:0004245', 'genital hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881284, 'HP:0034304', 'Epsilon wave', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881285, 'HP:0034304', 'Epsilon wave', 'MP:0003899', 'abnormal QT interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881286, 'HP:0034304', 'Epsilon wave', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881287, 'HP:0034304', 'Epsilon wave', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881288, 'HP:0034304', 'Epsilon wave', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881289, 'HP:0034304', 'Epsilon wave', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881290, 'HP:0034304', 'Epsilon wave', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881291, 'HP:0034304', 'Epsilon wave', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881292, 'HP:0034304', 'Epsilon wave', 'MP:0003820', 'increased left ventricle systolic pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881293, 'HP:0034304', 'Epsilon wave', 'MP:0011953', 'prolonged PQ interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881294, 'HP:0034304', 'Epsilon wave', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881295, 'HP:0034304', 'Epsilon wave', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881296, 'HP:0034304', 'Epsilon wave', 'MP:0010394', 'decreased QRS amplitude', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881297, 'HP:0034304', 'Epsilon wave', 'MP:0008568', 'abnormal interleukin secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881298, 'HP:0034304', 'Epsilon wave', 'MP:0010512', 'absent PR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881299, 'HP:0034304', 'Epsilon wave', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881300, 'HP:0034304', 'Epsilon wave', 'MP:0003882', 'abnormal pulse pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881301, 'HP:0034304', 'Epsilon wave', 'MP:0011514', 'skin hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881302, 'HP:0034304', 'Epsilon wave', 'MP:0011929', 'abnormal aortic valve flow', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881303, 'HP:0034304', 'Epsilon wave', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881304, 'HP:0034304', 'Epsilon wave', 'MP:0010756', 'decreased right ventricle peak pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881305, 'HP:0034304', 'Epsilon wave', 'MP:0011927', 'abnormal cardiac valve flow', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881306, 'HP:0034304', 'Epsilon wave', 'MP:0000233', 'abnormal blood flow velocity', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881307, 'HP:0034304', 'Epsilon wave', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881308, 'HP:0034304', 'Epsilon wave', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881309, 'HP:0034304', 'Epsilon wave', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881310, 'HP:0034304', 'Epsilon wave', 'MP:0031136', 'muscle hemorrhage', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881311, 'HP:0034304', 'Epsilon wave', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881312, 'HP:0034304', 'Epsilon wave', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881313, 'HP:0034304', 'Epsilon wave', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881314, 'HP:0034304', 'Epsilon wave', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881315, 'HP:0034304', 'Epsilon wave', 'MP:0009275', 'bruising', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881316, 'HP:0034304', 'Epsilon wave', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881317, 'HP:0034304', 'Epsilon wave', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881318, 'HP:0034304', 'Epsilon wave', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881319, 'HP:0034304', 'Epsilon wave', 'MP:0020419', 'decreased cardiac muscle relaxation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881320, 'HP:0034304', 'Epsilon wave', 'MP:0031109', 'subarachnoid hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881321, 'HP:0034304', 'Epsilon wave', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881322, 'HP:0034304', 'Epsilon wave', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881323, 'HP:0034304', 'Epsilon wave', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881324, 'HP:0034304', 'Epsilon wave', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881325, 'HP:0034304', 'Epsilon wave', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881326, 'HP:0034304', 'Epsilon wave', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881327, 'HP:0034304', 'Epsilon wave', 'MP:0001634', 'internal hemorrhage', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881328, 'HP:0034304', 'Epsilon wave', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881329, 'HP:0034304', 'Epsilon wave', 'MP:0011919', 'abnormal R wave', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881330, 'HP:0034304', 'Epsilon wave', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881331, 'HP:0034304', 'Epsilon wave', 'MP:0003901', 'abnormal PR interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881332, 'HP:0034304', 'Epsilon wave', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881333, 'HP:0034304', 'Epsilon wave', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881334, 'HP:0034304', 'Epsilon wave', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881335, 'HP:0034304', 'Epsilon wave', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881336, 'HP:0034304', 'Epsilon wave', 'MP:0002471', 'abnormal complement pathway', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881337, 'HP:0034304', 'Epsilon wave', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881338, 'HP:0034304', 'Epsilon wave', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881339, 'HP:0034304', 'Epsilon wave', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881340, 'HP:0034304', 'Epsilon wave', 'MP:0004216', 'salt-resistant hypertension', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881341, 'HP:0034304', 'Epsilon wave', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881342, 'HP:0034304', 'Epsilon wave', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881343, 'HP:0034304', 'Epsilon wave', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881344, 'HP:0034304', 'Epsilon wave', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881345, 'HP:0034304', 'Epsilon wave', 'MP:0013134', 'poor circulation in autopods', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881346, 'HP:0034304', 'Epsilon wave', 'MP:0012557', 'decreased calcium uptake by cardiac muscle', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881347, 'HP:0034304', 'Epsilon wave', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881348, 'HP:0034304', 'Epsilon wave', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881349, 'HP:0034304', 'Epsilon wave', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881350, 'HP:0034304', 'Epsilon wave', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881351, 'HP:0034304', 'Epsilon wave', 'MP:0001845', 'abnormal inflammatory response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881352, 'HP:0034304', 'Epsilon wave', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881353, 'HP:0034304', 'Epsilon wave', 'MP:0005000', 'abnormal immune tolerance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881354, 'HP:0034304', 'Epsilon wave', 'MP:0006044', 'tricuspid valve regurgitation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881355, 'HP:0034304', 'Epsilon wave', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881356, 'HP:0034304', 'Epsilon wave', 'MP:0003823', 'increased left ventricle developed pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881357, 'HP:0034304', 'Epsilon wave', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881358, 'HP:0034304', 'Epsilon wave', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881359, 'HP:0034304', 'Epsilon wave', 'MP:0011022', 'abnormal circadian regulation of systemic arterial blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881360, 'HP:0034304', 'Epsilon wave', 'MP:0010553', 'prolonged HV interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881361, 'HP:0034304', 'Epsilon wave', 'MP:0010520', 'sinoatrial block', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881362, 'HP:0034304', 'Epsilon wave', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881363, 'HP:0034304', 'Epsilon wave', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881364, 'HP:0034304', 'Epsilon wave', 'MP:0020096', 'high mean heart rate adaptation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881365, 'HP:0034304', 'Epsilon wave', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881366, 'HP:0034304', 'Epsilon wave', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881367, 'HP:0034304', 'Epsilon wave', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881368, 'HP:0034304', 'Epsilon wave', 'MP:0008950', 'ventricular tachycardia', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881369, 'HP:0034304', 'Epsilon wave', 'MP:0000343', 'abnormal response to cardiac infarction', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881370, 'HP:0034304', 'Epsilon wave', 'MP:0008776', 'increased right ventricle peak pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881371, 'HP:0034304', 'Epsilon wave', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881372, 'HP:0034304', 'Epsilon wave', 'MP:0013171', 'ear hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881373, 'HP:0034304', 'Epsilon wave', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881374, 'HP:0034304', 'Epsilon wave', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881375, 'HP:0034304', 'Epsilon wave', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881376, 'HP:0034304', 'Epsilon wave', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881377, 'HP:0034304', 'Epsilon wave', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881378, 'HP:0034304', 'Epsilon wave', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881379, 'HP:0034304', 'Epsilon wave', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881380, 'HP:0034304', 'Epsilon wave', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881381, 'HP:0034304', 'Epsilon wave', 'MP:0001864', 'vascular inflammation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881382, 'HP:0034304', 'Epsilon wave', 'MP:0002499', 'chronic inflammation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881383, 'HP:0034304', 'Epsilon wave', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881384, 'HP:0034304', 'Epsilon wave', 'MP:0008775', 'abnormal heart ventricle pressure', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881385, 'HP:0034304', 'Epsilon wave', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881386, 'HP:0034304', 'Epsilon wave', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881387, 'HP:0034304', 'Epsilon wave', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881388, 'HP:0034304', 'Epsilon wave', 'MP:0004752', 'decreased length of allograft survival', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881389, 'HP:0034304', 'Epsilon wave', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881390, 'HP:0034304', 'Epsilon wave', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881391, 'HP:0034304', 'Epsilon wave', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881392, 'HP:0034304', 'Epsilon wave', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881393, 'HP:0034304', 'Epsilon wave', 'MP:0013127', 'epistaxis', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881394, 'HP:0034304', 'Epsilon wave', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881395, 'HP:0034304', 'Epsilon wave', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881396, 'HP:0034304', 'Epsilon wave', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881397, 'HP:0034304', 'Epsilon wave', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881398, 'HP:0034304', 'Epsilon wave', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881399, 'HP:0034304', 'Epsilon wave', 'MP:0006114', 'cardiac murmur', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881400, 'HP:0034304', 'Epsilon wave', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881401, 'HP:0034304', 'Epsilon wave', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881402, 'HP:0034304', 'Epsilon wave', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881403, 'HP:0034304', 'Epsilon wave', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881404, 'HP:0034304', 'Epsilon wave', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881405, 'HP:0034304', 'Epsilon wave', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881406, 'HP:0034304', 'Epsilon wave', 'MP:0020346', 'abnormal myocardial fiber calcium currents', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881407, 'HP:0034304', 'Epsilon wave', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881408, 'HP:0034304', 'Epsilon wave', 'MP:0010636', 'bundle branch block', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881409, 'HP:0034304', 'Epsilon wave', 'MP:0001800', 'abnormal humoral immune response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881410, 'HP:0034304', 'Epsilon wave', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881411, 'HP:0034304', 'Epsilon wave', 'MP:0010637', 'sinus bradycardia', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881412, 'HP:0034304', 'Epsilon wave', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881413, 'HP:0034304', 'Epsilon wave', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881414, 'HP:0034304', 'Epsilon wave', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881415, 'HP:0034304', 'Epsilon wave', 'MP:0005004', 'abnormal lymphocyte anergy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881416, 'HP:0034304', 'Epsilon wave', 'MP:0006111', 'abnormal coronary circulation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881417, 'HP:0034304', 'Epsilon wave', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881418, 'HP:0034304', 'Epsilon wave', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881419, 'HP:0034304', 'Epsilon wave', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881420, 'HP:0034304', 'Epsilon wave', 'MP:0002723', 'abnormal immune serum protein physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881421, 'HP:0034304', 'Epsilon wave', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881422, 'HP:0034304', 'Epsilon wave', 'MP:0010559', 'heart block', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881423, 'HP:0034304', 'Epsilon wave', 'MP:0004156', 'abnormal QT variability', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881424, 'HP:0034304', 'Epsilon wave', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881425, 'HP:0034304', 'Epsilon wave', 'MP:0010507', 'shortened RR interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881426, 'HP:0034304', 'Epsilon wave', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881427, 'HP:0034304', 'Epsilon wave', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881428, 'HP:0034304', 'Epsilon wave', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881429, 'HP:0034304', 'Epsilon wave', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881430, 'HP:0034304', 'Epsilon wave', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881431, 'HP:0034304', 'Epsilon wave', 'MP:0004879', 'decreased systemic vascular resistance', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881432, 'HP:0034304', 'Epsilon wave', 'MP:0031128', 'cardiovascular shunt', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881433, 'HP:0034304', 'Epsilon wave', 'MP:0005245', 'hemarthrosis', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881434, 'HP:0034304', 'Epsilon wave', 'MP:0011920', 'abnormal S wave', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881435, 'HP:0034304', 'Epsilon wave', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881436, 'HP:0034304', 'Epsilon wave', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881437, 'HP:0034304', 'Epsilon wave', 'MP:0006047', 'aortic valve regurgitation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881438, 'HP:0034304', 'Epsilon wave', 'MP:0010570', 'prolonged ST segment', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881439, 'HP:0034304', 'Epsilon wave', 'MP:0020000', 'abnormal response to antigen', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881440, 'HP:0034304', 'Epsilon wave', 'MP:0003896', 'prolonged PR interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881441, 'HP:0034304', 'Epsilon wave', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881442, 'HP:0034304', 'Epsilon wave', 'MP:0006138', 'congestive heart failure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881443, 'HP:0034304', 'Epsilon wave', 'MP:0011937', 'shortened PP interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881444, 'HP:0034304', 'Epsilon wave', 'MP:0031152', 'subcutaneous hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881445, 'HP:0034304', 'Epsilon wave', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881446, 'HP:0034304', 'Epsilon wave', 'MP:0031170', 'abnormal vasculature physiology', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881447, 'HP:0034304', 'Epsilon wave', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881448, 'HP:0034304', 'Epsilon wave', 'MP:0012045', 'increased susceptibility to hypertension', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881449, 'HP:0034304', 'Epsilon wave', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881450, 'HP:0034304', 'Epsilon wave', 'MP:0002952', 'ventricular cardiomyopathy', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881451, 'HP:0034304', 'Epsilon wave', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881452, 'HP:0034304', 'Epsilon wave', 'MP:0004013', 'decreased pulmonary artery pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881453, 'HP:0034304', 'Epsilon wave', 'MP:0004085', 'abnormal heartbeat', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881454, 'HP:0034304', 'Epsilon wave', 'MP:0005001', 'abnormal clonal deletion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881455, 'HP:0034304', 'Epsilon wave', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881456, 'HP:0034304', 'Epsilon wave', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881457, 'HP:0034304', 'Epsilon wave', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881458, 'HP:0034304', 'Epsilon wave', 'MP:0004877', 'abnormal systemic vascular resistance', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881459, 'HP:0034304', 'Epsilon wave', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881460, 'HP:0034304', 'Epsilon wave', 'MP:0002972', 'abnormal cardiac muscle contractility', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881461, 'HP:0034304', 'Epsilon wave', 'MP:0005044', 'sepsis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881462, 'HP:0034304', 'Epsilon wave', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881463, 'HP:0034304', 'Epsilon wave', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.5833333333333334, 8.605269980670606, 2.240477811105893, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881464, 'HP:0034304', 'Epsilon wave', 'MP:0003900', 'shortened QT interval', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881465, 'HP:0034304', 'Epsilon wave', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881466, 'HP:0034304', 'Epsilon wave', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881467, 'HP:0034304', 'Epsilon wave', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881468, 'HP:0034304', 'Epsilon wave', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881469, 'HP:0034304', 'Epsilon wave', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881470, 'HP:0034304', 'Epsilon wave', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881471, 'HP:0034304', 'Epsilon wave', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881472, 'HP:0034304', 'Epsilon wave', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881473, 'HP:0034304', 'Epsilon wave', 'MP:0004009', 'abnormal diastolic filling velocity', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881474, 'HP:0034304', 'Epsilon wave', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881475, 'HP:0034304', 'Epsilon wave', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881476, 'HP:0034304', 'Epsilon wave', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881477, 'HP:0034304', 'Epsilon wave', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881478, 'HP:0034304', 'Epsilon wave', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881479, 'HP:0034304', 'Epsilon wave', 'MP:0010511', 'shortened PR interval', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881480, 'HP:0034304', 'Epsilon wave', 'MP:0012305', 'umbilical cord hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881481, 'HP:0034304', 'Epsilon wave', 'MP:0011931', 'abnormal pulmonary valve flow', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881482, 'HP:0034304', 'Epsilon wave', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881483, 'HP:0034304', 'Epsilon wave', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881484, 'HP:0034304', 'Epsilon wave', 'MP:0031129', 'left-to-right shunt', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881485, 'HP:0034304', 'Epsilon wave', 'MP:0031155', 'small intestine hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881486, 'HP:0034304', 'Epsilon wave', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881487, 'HP:0034304', 'Epsilon wave', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881488, 'HP:0034304', 'Epsilon wave', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.56, 8.605269980670606, 2.1952109668948765, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881489, 'HP:0034304', 'Epsilon wave', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881490, 'HP:0034304', 'Epsilon wave', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881491, 'HP:0034304', 'Epsilon wave', 'MP:0001916', 'intracerebral hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881492, 'HP:0034304', 'Epsilon wave', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881493, 'HP:0034304', 'Epsilon wave', 'MP:0005025', 'abnormal response to infection', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881494, 'HP:0034304', 'Epsilon wave', 'MP:0008543', 'atrial fibrillation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881495, 'HP:0034304', 'Epsilon wave', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881496, 'HP:0034304', 'Epsilon wave', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881497, 'HP:0034304', 'Epsilon wave', 'MP:0004086', 'absent heartbeat', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881498, 'HP:0034304', 'Epsilon wave', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881499, 'HP:0034304', 'Epsilon wave', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881500, 'HP:0034304', 'Epsilon wave', 'MP:0031153', 'stomach hemorrhage', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881501, 'HP:0034304', 'Epsilon wave', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881502, 'HP:0034304', 'Epsilon wave', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881503, 'HP:0034304', 'Epsilon wave', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881504, 'HP:0034304', 'Epsilon wave', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881505, 'HP:0034304', 'Epsilon wave', 'MP:0003009', 'abnormal cytokine secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881506, 'HP:0034304', 'Epsilon wave', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881507, 'HP:0034304', 'Epsilon wave', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881508, 'HP:0034304', 'Epsilon wave', 'MP:0010513', 'abnormal ventricular activation time', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881509, 'HP:0034304', 'Epsilon wave', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881510, 'HP:0034304', 'Epsilon wave', 'MP:0001633', 'poor circulation', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881511, 'HP:0034304', 'Epsilon wave', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881512, 'HP:0034304', 'Epsilon wave', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881513, 'HP:0034304', 'Epsilon wave', 'MP:0031192', 'coronary artery spasm', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881514, 'HP:0034304', 'Epsilon wave', 'MP:0006266', 'decreased pulse pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881515, 'HP:0034304', 'Epsilon wave', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881516, 'HP:0034304', 'Epsilon wave', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881517, 'HP:0034304', 'Epsilon wave', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881518, 'HP:0034304', 'Epsilon wave', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881519, 'HP:0034304', 'Epsilon wave', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881520, 'HP:0034304', 'Epsilon wave', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881521, 'HP:0034304', 'Epsilon wave', 'MP:0005333', 'decreased heart rate', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881522, 'HP:0034304', 'Epsilon wave', 'MP:0002626', 'increased heart rate', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881523, 'HP:0034304', 'Epsilon wave', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881524, 'HP:0034304', 'Epsilon wave', 'MP:0010368', 'abnormal lymphatic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881525, 'HP:0034304', 'Epsilon wave', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881526, 'HP:0034304', 'Epsilon wave', 'MP:0010506', 'prolonged RR interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881527, 'HP:0034304', 'Epsilon wave', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881528, 'HP:0034304', 'Epsilon wave', 'MP:0010392', 'prolonged QRS complex duration', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881529, 'HP:0034304', 'Epsilon wave', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881530, 'HP:0034304', 'Epsilon wave', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881531, 'HP:0034304', 'Epsilon wave', 'MP:0010505', 'abnormal T wave', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881532, 'HP:0034304', 'Epsilon wave', 'MP:0004122', 'abnormal sinus arrhythmia', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881533, 'HP:0034304', 'Epsilon wave', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881534, 'HP:0034304', 'Epsilon wave', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881535, 'HP:0034304', 'Epsilon wave', 'MP:0010510', 'absent P wave', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881536, 'HP:0034304', 'Epsilon wave', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881537, 'HP:0034304', 'Epsilon wave', 'MP:0012565', 'perivasculitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881538, 'HP:0034304', 'Epsilon wave', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881539, 'HP:0034304', 'Epsilon wave', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881540, 'HP:0034304', 'Epsilon wave', 'MP:0006048', 'pulmonary valve regurgitation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881541, 'HP:0034304', 'Epsilon wave', 'MP:0011918', 'abnormal PQ interval', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881542, 'HP:0034304', 'Epsilon wave', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881543, 'HP:0034304', 'Epsilon wave', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881544, 'HP:0034304', 'Epsilon wave', 'MP:0001835', 'abnormal antigen presentation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881545, 'HP:0034304', 'Epsilon wave', 'MP:0003438', 'abnormal carotid body physiology', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881546, 'HP:0034304', 'Epsilon wave', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881547, 'HP:0034304', 'Epsilon wave', 'MP:0001917', 'intraventricular hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881548, 'HP:0034304', 'Epsilon wave', 'MP:0004878', 'increased systemic vascular resistance', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881549, 'HP:0034304', 'Epsilon wave', 'MP:0006109', 'fibrillation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881550, 'HP:0034304', 'Epsilon wave', 'MP:0020345', 'abnormal myocardial fiber currents', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881551, 'HP:0034304', 'Epsilon wave', 'MP:0008744', 'abnormal B cell anergy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881552, 'HP:0034304', 'Epsilon wave', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881553, 'HP:0034304', 'Epsilon wave', 'MP:0005532', 'abnormal vascular resistance', 0.5384615384615384, 8.605269980670606, 2.1525814532018965, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881554, 'HP:0034304', 'Epsilon wave', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881555, 'HP:0034304', 'Epsilon wave', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881556, 'HP:0034304', 'Epsilon wave', 'MP:0006110', 'ventricular fibrillation', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881557, 'HP:0034304', 'Epsilon wave', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881558, 'HP:0034304', 'Epsilon wave', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881559, 'HP:0034304', 'Epsilon wave', 'MP:0001598', 'abnormal blood viscosity', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881560, 'HP:0034304', 'Epsilon wave', 'MP:0001837', 'defective assembly of class I molecules', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881561, 'HP:0034304', 'Epsilon wave', 'MP:0004486', 'decreased response of heart to induced stress', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881562, 'HP:0034304', 'Epsilon wave', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881563, 'HP:0034304', 'Epsilon wave', 'MP:0003034', 'increased pulmonary vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881564, 'HP:0034304', 'Epsilon wave', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881565, 'HP:0034304', 'Epsilon wave', 'MP:0003037', 'increased myocardial infarct size', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(881566, 'HP:0034304', 'Epsilon wave', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881567, 'HP:0034304', 'Epsilon wave', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881568, 'HP:0034304', 'Epsilon wave', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881569, 'HP:0034004', 'Parosmia', 'MP:0003467', 'abnormal single cell response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881570, 'HP:0034004', 'Parosmia', 'MP:0006190', 'retina ischemia', 0.4411764705882353, 5.161615048882964, 1.5090338332195563, 'UPHENO:0002910', 'abnormal face'),
(881571, 'HP:0034004', 'Parosmia', 'MP:0014157', 'alacrima', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881572, 'HP:0034004', 'Parosmia', 'MP:0003096', 'increased corneal light-scattering', 0.4411764705882353, 5.161615048882964, 1.5090338332195563, 'UPHENO:0002910', 'abnormal face'),
(881573, 'HP:0034004', 'Parosmia', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881574, 'HP:0034004', 'Parosmia', 'MP:0002578', 'impaired ability to fire action potentials', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881575, 'HP:0034004', 'Parosmia', 'MP:0012152', 'decreased a-wave latency', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881576, 'HP:0034004', 'Parosmia', 'MP:0012154', 'decreased b-wave latency', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881577, 'HP:0034004', 'Parosmia', 'MP:0003889', 'enhanced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881578, 'HP:0034004', 'Parosmia', 'MP:0003101', 'high myopia', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881579, 'HP:0034004', 'Parosmia', 'MP:0002635', 'reduced sensorimotor gating', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881580, 'HP:0034004', 'Parosmia', 'MP:0013450', 'abnormal lacrimal apparatus physiology', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881581, 'HP:0034004', 'Parosmia', 'MP:0004994', 'abnormal brain wave pattern', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881582, 'HP:0034004', 'Parosmia', 'MP:0012144', 'decreased b-wave amplitude', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881583, 'HP:0034004', 'Parosmia', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881584, 'HP:0034004', 'Parosmia', 'MP:0020220', 'decreased tear production', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881585, 'HP:0034004', 'Parosmia', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881586, 'HP:0034004', 'Parosmia', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881587, 'HP:0034004', 'Parosmia', 'MP:0006153', 'hypermetropia', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881588, 'HP:0034004', 'Parosmia', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881589, 'HP:0034004', 'Parosmia', 'MP:0002064', 'seizures', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881590, 'HP:0034004', 'Parosmia', 'MP:0006149', 'decreased visual acuity', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881591, 'HP:0034004', 'Parosmia', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881592, 'HP:0034004', 'Parosmia', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881593, 'HP:0034004', 'Parosmia', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881594, 'HP:0034004', 'Parosmia', 'MP:0020974', 'abnormal FO-wave shape', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881595, 'HP:0034004', 'Parosmia', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881596, 'HP:0034004', 'Parosmia', 'MP:0005402', 'abnormal action potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881597, 'HP:0034004', 'Parosmia', 'MP:0006152', 'tunnel vision', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881598, 'HP:0034004', 'Parosmia', 'MP:0012048', 'abnormal response to retina ischemic injury', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881599, 'HP:0034004', 'Parosmia', 'MP:0013596', 'abnormal vomeronasal organ physiology', 0.4864864864864865, 9.15868676709498, 2.110823854838275, 'UPHENO:0002907', 'abnormal nose'),
(881600, 'HP:0034004', 'Parosmia', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881601, 'HP:0034004', 'Parosmia', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881602, 'HP:0034004', 'Parosmia', 'MP:0012143', 'decreased a-wave amplitude', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881603, 'HP:0034004', 'Parosmia', 'MP:0012147', 'increased a-wave implicit time', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881604, 'HP:0034004', 'Parosmia', 'MP:0012033', 'abnormal ERG implicit time', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881605, 'HP:0034004', 'Parosmia', 'MP:0020439', 'absent b-wave', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881606, 'HP:0034004', 'Parosmia', 'MP:0012032', 'abnormal ERG latency', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881607, 'HP:0034004', 'Parosmia', 'MP:0031497', 'increased visual acuity', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881608, 'HP:0034004', 'Parosmia', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881609, 'HP:0034004', 'Parosmia', 'MP:0020980', 'increased FO-wave implicit time', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881610, 'HP:0034004', 'Parosmia', 'MP:0014132', 'abnormal tear film physiology', 0.4411764705882353, 5.161615048882964, 1.5090338332195563, 'UPHENO:0002910', 'abnormal face'),
(881611, 'HP:0034004', 'Parosmia', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881612, 'HP:0034004', 'Parosmia', 'MP:0003477', 'abnormal nerve fiber response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881613, 'HP:0034004', 'Parosmia', 'MP:0005253', 'abnormal eye physiology', 0.45454545454545453, 5.161615048882964, 1.5317273447265884, 'UPHENO:0002910', 'abnormal face'),
(881614, 'HP:0034004', 'Parosmia', 'MP:0011994', 'increased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881615, 'HP:0034004', 'Parosmia', 'MP:0012149', 'decreased b-wave implicit time', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881616, 'HP:0034004', 'Parosmia', 'MP:0006080', 'brain ischemia', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881617, 'HP:0034004', 'Parosmia', 'MP:0020962', 'increased c-wave amplitude', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881618, 'HP:0034004', 'Parosmia', 'MP:0005403', 'abnormal nerve conduction', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881619, 'HP:0034004', 'Parosmia', 'MP:0012153', 'increased b-wave latency', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881620, 'HP:0034004', 'Parosmia', 'MP:0002634', 'abnormal sensorimotor gating', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881621, 'HP:0034004', 'Parosmia', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881622, 'HP:0034004', 'Parosmia', 'MP:0003011', 'delayed dark adaptation', 0.4411764705882353, 5.161615048882964, 1.5090338332195563, 'UPHENO:0002910', 'abnormal face'),
(881623, 'HP:0034004', 'Parosmia', 'MP:0012040', 'abnormal c-wave shape', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881624, 'HP:0034004', 'Parosmia', 'MP:0003464', 'abnormal single cell response threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881625, 'HP:0034004', 'Parosmia', 'MP:0010748', 'abnormal visual evoked potential', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881626, 'HP:0034004', 'Parosmia', 'MP:0003474', 'abnormal summary potential intensity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881627, 'HP:0034004', 'Parosmia', 'MP:0020860', 'abnormal cornea physiology', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881628, 'HP:0034004', 'Parosmia', 'MP:0002090', 'abnormal vision', 0.4411764705882353, 5.161615048882964, 1.5090338332195563, 'UPHENO:0002910', 'abnormal face'),
(881629, 'HP:0034004', 'Parosmia', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881630, 'HP:0034004', 'Parosmia', 'MP:0012036', 'abnormal a-wave latency', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881631, 'HP:0034004', 'Parosmia', 'MP:0013806', 'encephalopathy', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881632, 'HP:0034004', 'Parosmia', 'MP:0012151', 'increased a-wave latency', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881633, 'HP:0034004', 'Parosmia', 'MP:0014179', 'abnormal blood-retina barrier function', 0.4722222222222222, 7.291997705654976, 1.855651734837046, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881634, 'HP:0034004', 'Parosmia', 'MP:0003878', 'abnormal ear physiology', 0.42424242424242425, 5.059610039003922, 1.4650942729627778, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881635, 'HP:0034004', 'Parosmia', 'MP:0020975', 'abnormal FO-wave amplitude', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881636, 'HP:0034004', 'Parosmia', 'MP:0013145', 'eye discharge', 0.4411764705882353, 5.161615048882964, 1.5090338332195563, 'UPHENO:0002910', 'abnormal face'),
(881637, 'HP:0034004', 'Parosmia', 'MP:0030144', 'abnormal facial muscle physiology', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881638, 'HP:0034004', 'Parosmia', 'MP:0005257', 'abnormal intraocular pressure', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881639, 'HP:0034004', 'Parosmia', 'MP:0020961', 'abnormal c-wave amplitude', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881640, 'HP:0034004', 'Parosmia', 'MP:0012037', 'abnormal b-wave latency', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881641, 'HP:0034004', 'Parosmia', 'MP:0020978', 'abnormal FO-wave implicit time', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881642, 'HP:0034004', 'Parosmia', 'MP:0001999', 'photosensitivity', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881643, 'HP:0034004', 'Parosmia', 'MP:0006150', 'double vision', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881644, 'HP:0034004', 'Parosmia', 'MP:0012030', 'abnormal a-wave amplitude', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881645, 'HP:0034004', 'Parosmia', 'MP:0012038', 'abnormal a-wave implicit time', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881646, 'HP:0034004', 'Parosmia', 'MP:0012031', 'abnormal b-wave amplitude', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881647, 'HP:0034004', 'Parosmia', 'MP:0012034', 'abnormal a-wave shape', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881648, 'HP:0034004', 'Parosmia', 'MP:0012150', 'increased b-wave implicit time', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881649, 'HP:0034004', 'Parosmia', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881650, 'HP:0034004', 'Parosmia', 'MP:0005551', 'abnormal eye electrophysiology', 0.4411764705882353, 5.161615048882964, 1.5090338332195563, 'UPHENO:0002910', 'abnormal face'),
(881651, 'HP:0034004', 'Parosmia', 'MP:0013468', 'chromodacryorrhea', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881652, 'HP:0034004', 'Parosmia', 'MP:0008145', 'hemeralopia', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881653, 'HP:0034004', 'Parosmia', 'MP:0021015', 'increased tau protein phosphorylation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881654, 'HP:0034004', 'Parosmia', 'MP:0012145', 'increased a-wave amplitude', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881655, 'HP:0034004', 'Parosmia', 'MP:0012035', 'abnormal b-wave shape', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881656, 'HP:0034004', 'Parosmia', 'MP:0003880', 'abnormal central pattern generator function', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881657, 'HP:0034004', 'Parosmia', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4375, 7.291997705654976, 1.7861268141495585, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881658, 'HP:0034004', 'Parosmia', 'MP:0020977', 'decreased FO-wave amplitude', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881659, 'HP:0034004', 'Parosmia', 'MP:0030147', 'abnormal digastric muscle physiology', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881660, 'HP:0034004', 'Parosmia', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881661, 'HP:0034004', 'Parosmia', 'MP:0003633', 'abnormal nervous system physiology', 0.45161290322580644, 7.291997705654976, 1.8147066578835167, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881662, 'HP:0034004', 'Parosmia', 'MP:0003100', 'myopia', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881663, 'HP:0034004', 'Parosmia', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.4411764705882353, 5.161615048882964, 1.5090338332195563, 'UPHENO:0002910', 'abnormal face'),
(881664, 'HP:0034004', 'Parosmia', 'MP:0005645', 'abnormal hypothalamus physiology', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881665, 'HP:0034004', 'Parosmia', 'MP:0012006', 'abnormal hippocampus physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881666, 'HP:0034004', 'Parosmia', 'MP:0011832', 'abnormal visual acuity', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881667, 'HP:0034004', 'Parosmia', 'MP:0001337', 'dry eyes', 0.4411764705882353, 5.161615048882964, 1.5090338332195563, 'UPHENO:0002910', 'abnormal face'),
(881668, 'HP:0034004', 'Parosmia', 'MP:0005258', 'ocular hypertension', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881669, 'HP:0034004', 'Parosmia', 'MP:0012146', 'increased b-wave amplitude', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881670, 'HP:0034004', 'Parosmia', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881671, 'HP:0034004', 'Parosmia', 'MP:0001963', 'abnormal hearing physiology', 0.4117647058823529, 5.059610039003922, 1.4433879726497136, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881672, 'HP:0034004', 'Parosmia', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881673, 'HP:0034004', 'Parosmia', 'MP:0003471', 'abnormal summary potential threshold', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881674, 'HP:0034004', 'Parosmia', 'MP:0012039', 'abnormal b-wave implicit time', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881675, 'HP:0034004', 'Parosmia', 'MP:0004022', 'abnormal cone electrophysiology', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881676, 'HP:0034004', 'Parosmia', 'MP:0020219', 'increased tear production', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881677, 'HP:0034004', 'Parosmia', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881678, 'HP:0034004', 'Parosmia', 'MP:0010749', 'absent visual evoked potential', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881679, 'HP:0034004', 'Parosmia', 'MP:0002001', 'blindness', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881680, 'HP:0034004', 'Parosmia', 'MP:0020963', 'decreased c-wave amplitude', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881681, 'HP:0034004', 'Parosmia', 'MP:0006251', 'eyelid apraxia', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881682, 'HP:0034004', 'Parosmia', 'MP:0003470', 'abnormal summary potential', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881683, 'HP:0034004', 'Parosmia', 'MP:0020979', 'decreased FO-wave implicit time', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881684, 'HP:0034004', 'Parosmia', 'MP:0020976', 'increased FO-wave amplitude', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881685, 'HP:0034004', 'Parosmia', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881686, 'HP:0034004', 'Parosmia', 'MP:0020218', 'abnormal tear production', 0.4411764705882353, 5.161615048882964, 1.5090338332195563, 'UPHENO:0002910', 'abnormal face'),
(881687, 'HP:0034004', 'Parosmia', 'MP:0020960', 'increased c-wave implicit time', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881688, 'HP:0034004', 'Parosmia', 'MP:0012148', 'decreased a-wave implicit time', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881689, 'HP:0034004', 'Parosmia', 'MP:0008814', 'decreased nerve conduction velocity', 0.4117647058823529, 7.291997705654976, 1.7327975330556693, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881690, 'HP:0034004', 'Parosmia', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881691, 'HP:0034004', 'Parosmia', 'MP:0005260', 'ocular hypotension', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881692, 'HP:0034004', 'Parosmia', 'MP:0003463', 'abnormal single cell response', 0.42424242424242425, 7.291997705654976, 1.7588561010546777, 'UPHENO:0002433', 'abnormality of nervous system physiology'),
(881693, 'HP:0034004', 'Parosmia', 'MP:0020959', 'decreased c-wave implicit time', 0.40540540540540543, 5.161615048882964, 1.4465637356988594, 'UPHENO:0002910', 'abnormal face'),
(881694, 'HP:0034004', 'Parosmia', 'MP:0020958', 'abnormal c-wave implicit time', 0.4166666666666667, 5.161615048882964, 1.466517281532873, 'UPHENO:0002910', 'abnormal face'),
(881695, 'HP:0034004', 'Parosmia', 'MP:0004021', 'abnormal rod electrophysiology', 0.42857142857142855, 5.161615048882964, 1.4873199841444866, 'UPHENO:0002910', 'abnormal face'),
(881696, 'HP:0000667', 'Phthisis bulbi', 'MP:0001306', 'small lens', 0.41509433962264153, 6.679863125803252, 1.6651646684261996, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881697, 'HP:0000667', 'Phthisis bulbi', 'MP:0005176', 'eyelids fail to open', 0.44, 8.581084971325078, 1.9431102355201144, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(881698, 'HP:0000667', 'Phthisis bulbi', 'MP:0006164', 'ectropion', 0.42, 6.679863125803252, 1.674975376785392, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881699, 'HP:0000667', 'Phthisis bulbi', 'MP:0006166', 'eyelid retraction', 0.4117647058823529, 6.679863125803252, 1.6584727538704853, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881700, 'HP:0000667', 'Phthisis bulbi', 'MP:0008815', 'anterior staphyloma', 0.40425531914893614, 6.679863125803252, 1.6432803168640473, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881701, 'HP:0000667', 'Phthisis bulbi', 'MP:0002092', 'abnormal eye morphology', 0.4090909090909091, 6.679863125803252, 1.6530793322577395, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881702, 'HP:0000667', 'Phthisis bulbi', 'MP:0001296', 'macrophthalmia', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(881703, 'HP:0000667', 'Phthisis bulbi', 'MP:0006225', 'ocular rupture', 0.46808510638297873, 8.581084971325078, 2.004165180738374, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(881704, 'HP:0000667', 'Phthisis bulbi', 'MP:0031289', 'unilateral microphthalmia', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(881705, 'HP:0000667', 'Phthisis bulbi', 'MP:0003102', 'sclera thinning', 0.41509433962264153, 6.679863125803252, 1.6651646684261996, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881706, 'HP:0000667', 'Phthisis bulbi', 'MP:0013396', 'eyelid hyperplasia', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881707, 'HP:0000667', 'Phthisis bulbi', 'MP:0030063', 'abnormal face size', 0.41304347826086957, 5.913369942082322, 1.5628432068256108, 'UPHENO:0087472', 'abnormal face morphology'),
(881708, 'HP:0000667', 'Phthisis bulbi', 'MP:0014176', 'abnormal cilary zonule morphology', 0.40425531914893614, 6.679863125803252, 1.6432803168640473, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881709, 'HP:0000667', 'Phthisis bulbi', 'MP:0006249', 'phthisis bulbi', 0.5102040816326531, 9.255471829629862, 2.1730576395745222, 'UPHENO:0072814', 'abnormally formed anatomical entity in independent continuant'),
(881710, 'HP:0000667', 'Phthisis bulbi', 'MP:0005195', 'abnormal posterior eye segment morphology', 0.41304347826086957, 6.679863125803252, 1.6610460257886595, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881711, 'HP:0000667', 'Phthisis bulbi', 'MP:0002699', 'abnormal vitreous body morphology', 0.40816326530612246, 6.679863125803252, 1.651204028951546, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881712, 'HP:0000667', 'Phthisis bulbi', 'MP:0006248', 'lagophthalmos', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(881713, 'HP:0000667', 'Phthisis bulbi', 'MP:0010081', 'posterior microphthalmia', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(881714, 'HP:0000667', 'Phthisis bulbi', 'MP:0005193', 'abnormal anterior eye segment morphology', 0.41304347826086957, 6.679863125803252, 1.6610460257886595, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881715, 'HP:0000667', 'Phthisis bulbi', 'MP:0031317', 'spherophakia', 0.4074074074074074, 6.679863125803252, 1.6496744278553401, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881716, 'HP:0000667', 'Phthisis bulbi', 'MP:0009274', 'buphthalmos', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(881717, 'HP:0000667', 'Phthisis bulbi', 'MP:0031432', 'cornea perforation', 0.4074074074074074, 6.679863125803252, 1.6496744278553401, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881718, 'HP:0000667', 'Phthisis bulbi', 'MP:0008841', 'ruptured lens capsule', 0.41509433962264153, 6.679863125803252, 1.6651646684261996, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881719, 'HP:0000667', 'Phthisis bulbi', 'MP:0003671', 'abnormal eyelid aperture', 0.42, 6.679863125803252, 1.674975376785392, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881720, 'HP:0000667', 'Phthisis bulbi', 'MP:0006209', 'calcified intraocular region', 0.46808510638297873, 8.581084971325078, 2.004165180738374, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(881721, 'HP:0000667', 'Phthisis bulbi', 'MP:0001297', 'microphthalmia', 0.43137254901960786, 8.581084971325078, 1.9239658254330683, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(881722, 'HP:0000667', 'Phthisis bulbi', 'MP:0002698', 'abnormal sclera morphology', 0.41304347826086957, 6.679863125803252, 1.6610460257886595, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881723, 'HP:0000667', 'Phthisis bulbi', 'MP:0014087', 'retrolental blood', 0.40425531914893614, 6.679863125803252, 1.6432803168640473, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881724, 'HP:0000667', 'Phthisis bulbi', 'MP:0031290', 'bilateral microphthalmia', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(881725, 'HP:0000667', 'Phthisis bulbi', 'MP:0031498', 'abnormal cornea size', 0.4074074074074074, 6.679863125803252, 1.6496744278553401, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881726, 'HP:0000667', 'Phthisis bulbi', 'MP:0001305', 'enlarged lens', 0.41509433962264153, 6.679863125803252, 1.6651646684261996, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881727, 'HP:0000667', 'Phthisis bulbi', 'MP:0002697', 'abnormal eye size', 0.46808510638297873, 8.581084971325078, 2.004165180738374, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(881728, 'HP:0000667', 'Phthisis bulbi', 'MP:0009829', 'enlarged eye anterior chamber', 0.4074074074074074, 6.679863125803252, 1.6496744278553401, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(881729, 'HP:0002339', 'Abnormal caudate nucleus morphology', 'MP:0004102', 'abnormal dorsal striatum morphology', 0.40816326530612246, 13.33412877350486, 2.332916959560727, 'UPHENO:0087648', 'abnormal caudate-putamen morphology'),
(881730, 'HP:0002339', 'Abnormal caudate nucleus morphology', 'MP:0013838', 'small caudate nucleus', 0.45454545454545453, 14.87018167374507, 2.5998410505386556, 'UPHENO:0076708', 'abnormal caudate nucleus morphology'),
(881731, 'HP:0002339', 'Abnormal caudate nucleus morphology', 'MP:0012468', 'decreased striatum size', 0.4528301886792453, 14.022184767190119, 2.519854871579302, 'UPHENO:0020212', 'abnormal striatum morphology'),
(881732, 'HP:0002339', 'Abnormal caudate nucleus morphology', 'MP:0030986', 'striatum atrophy', 0.42857142857142855, 14.022184767190119, 2.451429737391466, 'UPHENO:0020212', 'abnormal striatum morphology'),
(881733, 'HP:0002339', 'Abnormal caudate nucleus morphology', 'MP:0012467', 'increased striatum size', 0.4528301886792453, 14.022184767190119, 2.519854871579302, 'UPHENO:0020212', 'abnormal striatum morphology'),
(881734, 'HP:0002339', 'Abnormal caudate nucleus morphology', 'MP:0004078', 'abnormal caudate nucleus morphology', 0.42, 14.87018167374507, 2.499095096824634, 'UPHENO:0076708', 'abnormal caudate nucleus morphology'),
(881735, 'HP:0030890', 'Hyperintensity of cerebral white matter on MRI', 'MP:0012461', 'increased brain internal capsule size', 0.4423076923076923, 10.963291078136551, 2.202078104170715, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(881736, 'HP:0030890', 'Hyperintensity of cerebral white matter on MRI', 'MP:0008128', 'abnormal brain internal capsule morphology', 0.40425531914893614, 10.963291078136551, 2.1052241528432964, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(881737, 'HP:0030890', 'Hyperintensity of cerebral white matter on MRI', 'MP:0008222', 'decreased hippocampal commissure size', 0.40350877192982454, 10.963291078136551, 2.103279372610325, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(881738, 'HP:0030890', 'Hyperintensity of cerebral white matter on MRI', 'MP:0020573', 'abnormal corpus callosum size', 0.41818181818181815, 10.963291078136551, 2.1411793470682574, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(881739, 'HP:0030890', 'Hyperintensity of cerebral white matter on MRI', 'MP:0000791', 'delaminated cerebral cortex', 0.4375, 8.700256672302757, 1.9509900804802818, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(881740, 'HP:0030890', 'Hyperintensity of cerebral white matter on MRI', 'MP:0020140', 'increased brain external capsule size', 0.45098039215686275, 10.963291078136551, 2.2235623017464246, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(881741, 'HP:0030890', 'Hyperintensity of cerebral white matter on MRI', 'MP:0020139', 'abnormal brain external capsule morphology', 0.41304347826086957, 10.963291078136551, 2.127983994324177, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(881742, 'HP:0030890', 'Hyperintensity of cerebral white matter on MRI', 'MP:0012462', 'decreased brain internal capsule size', 0.4423076923076923, 10.963291078136551, 2.202078104170715, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(881743, 'HP:0030890', 'Hyperintensity of cerebral white matter on MRI', 'MP:0020569', 'abnormal premotor cortex size', 0.42, 8.700256672302757, 1.9115720761632709, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(881744, 'HP:0030890', 'Hyperintensity of cerebral white matter on MRI', 'MP:0008224', 'increased hippocampal commissure size', 0.40350877192982454, 10.963291078136551, 2.103279372610325, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(881745, 'HP:0030890', 'Hyperintensity of cerebral white matter on MRI', 'MP:0020141', 'decreased brain external capsule size', 0.45098039215686275, 10.963291078136551, 2.2235623017464246, 'UPHENO:0081562', 'abnormal cerebral hemisphere white matter morphology'),
(881746, 'HP:0030890', 'Hyperintensity of cerebral white matter on MRI', 'MP:0020066', 'abnormal neocortex size', 0.42, 8.700256672302757, 1.9115720761632709, 'UPHENO:0087531', 'abnormal cerebral hemisphere morphology'),
(881747, 'HP:0030890', 'Hyperintensity of cerebral white matter on MRI', 'MP:0012137', 'abnormal forebrain size', 0.43478260869565216, 9.371930806217245, 2.0186016259882185, 'UPHENO:0020888', 'abnormal forebrain morphology'),
(881748, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0000736', 'delayed muscle development', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881749, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0003358', 'abnormal hypaxial muscle morphology', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881750, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0000752', 'dystrophic muscle', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881751, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0004819', 'decreased skeletal muscle mass', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881752, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0009407', 'increased skeletal muscle fiber density', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881753, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0003939', 'abnormal myotome morphology', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881754, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0031112', 'rhabdomyolysis', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881755, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0004817', 'abnormal skeletal muscle mass', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881756, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0000759', 'abnormal skeletal muscle morphology', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881757, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0000733', 'abnormal muscle development', 0.48, 7.206267831629091, 1.8598410037371376, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881758, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0002108', 'abnormal muscle morphology', 0.5, 7.206267831629091, 1.898192275775704, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881759, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0004233', 'abnormal muscle weight', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881760, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0021138', 'abnormal multifidus muscle morphology', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881761, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0004248', 'abnormal epaxial muscle morphology', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881762, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0000767', 'abnormal smooth muscle morphology', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881763, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0009408', 'decreased skeletal muscle fiber density', 0.4444444444444444, 7.206267831629091, 1.789632840262567, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881764, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0004818', 'increased skeletal muscle mass', 0.42857142857142855, 7.206267831629091, 1.7573845621461486, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881765, 'HP:0034369', 'Decreased level of coenzyme Q10 in skeletal muscle', 'MP:0000731', 'increased collagen deposition in the muscles', 0.46153846153846156, 7.206267831629091, 1.8237241481222417, 'UPHENO:0076710', 'abnormal muscle organ morphology'),
(881766, 'HP:0034711', 'Peripheral axonal distension', 'MP:0002878', 'abnormal corticospinal tract morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881767, 'HP:0034711', 'Peripheral axonal distension', 'MP:0000959', 'abnormal somatic sensory system morphology', 0.4827586206896552, 7.61846258113911, 1.9177795721736288, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881768, 'HP:0034711', 'Peripheral axonal distension', 'MP:0008312', 'abnormal sympathetic postganglionic fiber morphology', 0.4666666666666667, 7.61846258113911, 1.885545687026681, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881769, 'HP:0034711', 'Peripheral axonal distension', 'MP:0013562', 'abnormal circumventricular organ morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881770, 'HP:0034711', 'Peripheral axonal distension', 'MP:0000955', 'abnormal spinal cord morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881771, 'HP:0034711', 'Peripheral axonal distension', 'MP:0008319', 'abnormal sympathetic afferent fiber morphology', 0.45161290322580644, 7.61846258113911, 1.8548843641546513, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881772, 'HP:0034711', 'Peripheral axonal distension', 'MP:0003994', 'abnormal dorsal spinal root morphology', 0.4375, 7.61846258113911, 1.8256717610918893, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881773, 'HP:0034711', 'Peripheral axonal distension', 'MP:0003632', 'abnormal nervous system morphology', 0.5, 5.028460092616607, 1.5856323805688075, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881774, 'HP:0034711', 'Peripheral axonal distension', 'MP:0014064', 'argyrophilic inclusion bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881775, 'HP:0034711', 'Peripheral axonal distension', 'MP:0013915', 'abnormal brachial plexus formation', 0.5, 7.61846258113911, 1.951725208775445, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881776, 'HP:0034711', 'Peripheral axonal distension', 'MP:0014063', 'Lafora bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881777, 'HP:0034711', 'Peripheral axonal distension', 'MP:0002200', 'abnormal brain ventricular system morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881778, 'HP:0034711', 'Peripheral axonal distension', 'MP:0002184', 'abnormal innervation', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881779, 'HP:0034711', 'Peripheral axonal distension', 'MP:0001890', 'anencephaly', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881780, 'HP:0034711', 'Peripheral axonal distension', 'MP:0008313', 'abnormal parasympathetic postganglionic fiber morphology', 0.4666666666666667, 7.61846258113911, 1.885545687026681, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881781, 'HP:0034711', 'Peripheral axonal distension', 'MP:0008026', 'abnormal brain white matter morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881782, 'HP:0034711', 'Peripheral axonal distension', 'MP:0005277', 'abnormal brainstem morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881783, 'HP:0034711', 'Peripheral axonal distension', 'MP:0000961', 'abnormal dorsal root ganglion morphology', 0.4117647058823529, 7.61846258113911, 1.7711617667504165, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881784, 'HP:0034711', 'Peripheral axonal distension', 'MP:0000913', 'abnormal brain development', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881785, 'HP:0034711', 'Peripheral axonal distension', 'MP:0008025', 'brain vacuoles', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881786, 'HP:0034711', 'Peripheral axonal distension', 'MP:0002752', 'abnormal somatic nervous system morphology', 0.5185185185185185, 7.61846258113911, 1.9875396677704371, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881787, 'HP:0034711', 'Peripheral axonal distension', 'MP:0021002', 'brain lesion', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881788, 'HP:0034711', 'Peripheral axonal distension', 'MP:0008493', 'alpha-synuclein inclusion body', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881789, 'HP:0034711', 'Peripheral axonal distension', 'MP:0002653', 'abnormal ependyma morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881790, 'HP:0034711', 'Peripheral axonal distension', 'MP:0001051', 'abnormal somatic motor system morphology', 0.4827586206896552, 7.61846258113911, 1.9177795721736288, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881791, 'HP:0034711', 'Peripheral axonal distension', 'MP:0004997', 'increased CNS synapse formation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881792, 'HP:0034711', 'Peripheral axonal distension', 'MP:0002751', 'abnormal autonomic nervous system morphology', 0.5185185185185185, 7.61846258113911, 1.9875396677704371, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881793, 'HP:0034711', 'Peripheral axonal distension', 'MP:0008311', 'abnormal parasympathetic preganglionic fiber morphology', 0.4666666666666667, 7.61846258113911, 1.885545687026681, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881794, 'HP:0034711', 'Peripheral axonal distension', 'MP:0001044', 'abnormal enteric nervous system morphology', 0.4827586206896552, 7.61846258113911, 1.9177795721736288, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881795, 'HP:0034711', 'Peripheral axonal distension', 'MP:0014067', 'Hirano bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881796, 'HP:0034711', 'Peripheral axonal distension', 'MP:0001052', 'abnormal innervation pattern to muscle', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881797, 'HP:0034711', 'Peripheral axonal distension', 'MP:0001034', 'abnormal parasympathetic ganglion morphology', 0.42424242424242425, 7.61846258113911, 1.7977972728933185, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881798, 'HP:0034711', 'Peripheral axonal distension', 'MP:0031468', 'abnormal taste bud morphology', 0.4375, 7.61846258113911, 1.8256717610918893, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881799, 'HP:0034711', 'Peripheral axonal distension', 'MP:0002778', 'meroanencephaly', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881800, 'HP:0034711', 'Peripheral axonal distension', 'MP:0012545', 'syringomyelia', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881801, 'HP:0034711', 'Peripheral axonal distension', 'MP:0004996', 'abnormal CNS synapse formation', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881802, 'HP:0034711', 'Peripheral axonal distension', 'MP:0008317', 'abnormal paravertebral ganglion morphology', 0.4117647058823529, 7.61846258113911, 1.7711617667504165, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881803, 'HP:0034711', 'Peripheral axonal distension', 'MP:0008318', 'abnormal splanchnic nerve morphology', 0.4375, 7.61846258113911, 1.8256717610918893, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881804, 'HP:0034711', 'Peripheral axonal distension', 'MP:0003634', 'abnormal glial cell morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881805, 'HP:0034711', 'Peripheral axonal distension', 'MP:0003993', 'abnormal ventral spinal root morphology', 0.4375, 7.61846258113911, 1.8256717610918893, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881806, 'HP:0034711', 'Peripheral axonal distension', 'MP:0012711', 'diplomyelia', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881807, 'HP:0034711', 'Peripheral axonal distension', 'MP:0001033', 'abnormal parasympathetic system morphology', 0.4827586206896552, 7.61846258113911, 1.9177795721736288, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881808, 'HP:0034711', 'Peripheral axonal distension', 'MP:0005623', 'abnormal meninges morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881809, 'HP:0034711', 'Peripheral axonal distension', 'MP:0000841', 'abnormal hindbrain morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881810, 'HP:0034711', 'Peripheral axonal distension', 'MP:0002924', 'delayed CNS synapse formation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881811, 'HP:0034711', 'Peripheral axonal distension', 'MP:0020370', 'abnormal glymphatic system morphology', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881812, 'HP:0034711', 'Peripheral axonal distension', 'MP:0014065', 'Lewy bodies', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881813, 'HP:0034711', 'Peripheral axonal distension', 'MP:0014062', 'nervous system inclusion bodies', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881814, 'HP:0034711', 'Peripheral axonal distension', 'MP:0020452', 'abnormal axon radial sorting', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881815, 'HP:0034711', 'Peripheral axonal distension', 'MP:0001008', 'abnormal sympathetic ganglion morphology', 0.42424242424242425, 7.61846258113911, 1.7977972728933185, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881816, 'HP:0034711', 'Peripheral axonal distension', 'MP:0014149', 'abnormal lacrimal gland innervation pattern', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881817, 'HP:0034711', 'Peripheral axonal distension', 'MP:0012260', 'encephalomeningocele', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881818, 'HP:0034711', 'Peripheral axonal distension', 'MP:0000960', 'abnormal sensory ganglion morphology', 0.4375, 7.61846258113911, 1.8256717610918893, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881819, 'HP:0034711', 'Peripheral axonal distension', 'MP:0000778', 'abnormal nervous system tract morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881820, 'HP:0034711', 'Peripheral axonal distension', 'MP:0003861', 'abnormal nervous system development', 0.48, 5.028460092616607, 1.5535961008112666, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881821, 'HP:0034711', 'Peripheral axonal distension', 'MP:0000972', 'abnormal mechanoreceptor morphology', 0.4375, 7.61846258113911, 1.8256717610918893, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881822, 'HP:0034711', 'Peripheral axonal distension', 'MP:0013935', 'basal brain tissue herniation', 0.42857142857142855, 5.028460092616607, 1.4680103287808015, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881823, 'HP:0034711', 'Peripheral axonal distension', 'MP:0014066', 'Rosenthal fibers', 0.46153846153846156, 5.028460092616607, 1.5234263142842908, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881824, 'HP:0034711', 'Peripheral axonal distension', 'MP:0003894', 'abnormal Purkinje cell innervation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881825, 'HP:0034711', 'Peripheral axonal distension', 'MP:0001078', 'abnormal phrenic nerve morphology', 0.4375, 7.61846258113911, 1.8256717610918893, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881826, 'HP:0034711', 'Peripheral axonal distension', 'MP:0008310', 'abnormal sympathetic preganglionic fiber morphology', 0.4666666666666667, 7.61846258113911, 1.885545687026681, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881827, 'HP:0034711', 'Peripheral axonal distension', 'MP:0009685', 'abnormal spinal cord motor column morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881828, 'HP:0034711', 'Peripheral axonal distension', 'MP:0000958', 'peripheral nervous system degeneration', 0.42424242424242425, 7.61846258113911, 1.7977972728933185, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881829, 'HP:0034711', 'Peripheral axonal distension', 'MP:0010800', 'abnormal submucous nerve plexus morphology', 0.45161290322580644, 7.61846258113911, 1.8548843641546513, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881830, 'HP:0034711', 'Peripheral axonal distension', 'MP:0001077', 'abnormal spinal nerve morphology', 0.4666666666666667, 7.61846258113911, 1.885545687026681, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881831, 'HP:0034711', 'Peripheral axonal distension', 'MP:0004998', 'decreased CNS synapse formation', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881832, 'HP:0034711', 'Peripheral axonal distension', 'MP:0002152', 'abnormal brain morphology', 0.4444444444444444, 5.028460092616607, 1.4949485450255628, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881833, 'HP:0034711', 'Peripheral axonal distension', 'MP:0008027', 'abnormal spinal cord white matter morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881834, 'HP:0034711', 'Peripheral axonal distension', 'MP:0000783', 'abnormal forebrain morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881835, 'HP:0034711', 'Peripheral axonal distension', 'MP:0003329', 'amyloid beta deposits', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881836, 'HP:0034711', 'Peripheral axonal distension', 'MP:0001007', 'abnormal sympathetic system morphology', 0.4827586206896552, 7.61846258113911, 1.9177795721736288, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881837, 'HP:0034711', 'Peripheral axonal distension', 'MP:0009688', 'abnormal spinal cord central canal morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881838, 'HP:0034711', 'Peripheral axonal distension', 'MP:0008503', 'abnormal spinal cord grey matter morphology', 0.41379310344827586, 5.028460092616607, 1.4424777666534865, 'UPHENO:0076702', 'abnormal nervous system morphology'),
(881839, 'HP:0034711', 'Peripheral axonal distension', 'MP:0020503', 'abnormal sympathetic trunk morphology', 0.45161290322580644, 7.61846258113911, 1.8548843641546513, 'UPHENO:0076722', 'abnormal peripheral nervous system morphology'),
(881840, 'HP:0005720', 'Shortening of all metacarpals', 'MP:0004634', 'short metacarpal bones', 0.5058823529411764, 14.192109768632433, 2.6794659697326315, 'UPHENO:0046539', 'decreased length of metacarpal bone'),
(881841, 'HP:0005720', 'Shortening of all metacarpals', 'MP:0004637', 'metacarpal bone hypoplasia', 0.45454545454545453, 13.062826751687464, 2.4367290623896416, 'UPHENO:0080160', 'aplasia or hypoplasia of metacarpal bone'),
(881842, 'HP:0005720', 'Shortening of all metacarpals', 'MP:0004355', 'short radius', 0.40217391304347827, 10.906707549770182, 2.0943718040768027, 'UPHENO:0046538', 'decreased length of long bone'),
(881843, 'HP:0005720', 'Shortening of all metacarpals', 'MP:0004351', 'short humerus', 0.40217391304347827, 10.906707549770182, 2.0943718040768027, 'UPHENO:0046538', 'decreased length of long bone'),
(881844, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0011963', 'abnormal total retina thickness', 0.41379310344827586, 9.356059413574362, 1.9676058702873884, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881845, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0006187', 'retina deposits', 0.41379310344827586, 9.356059413574362, 1.9676058702873884, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881846, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0009772', 'abnormal retina development', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881847, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0003099', 'retina detachment', 0.43548387096774194, 9.356059413574362, 2.01851751798877, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881848, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0003727', 'abnormal retina layer morphology', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881849, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0011964', 'increased total retina thickness', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881850, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0020443', 'tractional retina detachment', 0.42857142857142855, 9.356059413574362, 2.0024334567407545, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881851, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0011965', 'decreased total retina thickness', 0.4067796610169492, 9.356059413574362, 1.9508599838810101, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881852, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0001329', 'retina hyperplasia', 0.42857142857142855, 9.356059413574362, 2.0024334567407545, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881853, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0003455', 'decreased susceptibility to induced retina damage', 0.41379310344827586, 9.356059413574362, 1.9676058702873884, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881854, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0020441', 'rhegmatogenous retina detachment', 0.42857142857142855, 9.356059413574362, 2.0024334567407545, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881855, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0006186', 'retina fibrosis', 0.45, 9.356059413574362, 2.0518837043332803, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881856, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0001325', 'abnormal retina morphology', 0.42105263157894735, 9.356059413574362, 1.9847905273087305, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881857, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0020038', 'retina macular degeneration', 0.4153846153846154, 9.356059413574362, 1.9713860963857883, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881858, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0012671', 'retina spots', 0.41379310344827586, 9.356059413574362, 1.9676058702873884, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881859, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0020442', 'serous retina detachment', 0.42857142857142855, 9.356059413574362, 2.0024334567407545, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881860, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0008512', 'disorganized retina inner nuclear layer', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881861, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0001328', 'disorganized retina layers', 0.40625, 9.356059413574362, 1.9495894790351596, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881862, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0008516', 'disorganized retina outer nuclear layer', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881863, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0021107', 'retina fold', 0.41379310344827586, 9.356059413574362, 1.9676058702873884, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881864, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0006188', 'calcified retina', 0.4444444444444444, 9.356059413574362, 2.0391784199170195, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881865, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0010707', 'decreased ventral retina size', 0.41379310344827586, 9.356059413574362, 1.9676058702873884, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881866, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0001326', 'retina degeneration', 0.4426229508196721, 9.356059413574362, 2.0349954854201657, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881867, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0008520', 'disorganized retina outer plexiform layer', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881868, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0009392', 'retina gliosis', 0.41379310344827586, 9.356059413574362, 1.9676058702873884, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881869, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0002984', 'retina hypoplasia', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881870, 'HP:0007703', 'Abnormality of retinal pigmentation', 'MP:0008509', 'disorganized retina ganglion layer', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(881871, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0014030', 'abnormal mucous gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881872, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002471', 'abnormal complement pathway', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881873, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881874, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013134', 'poor circulation in autopods', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881875, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031118', 'cardiovalvulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881876, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881877, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004228', 'decreased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881878, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881879, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881880, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008747', 'abnormal T cell anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881881, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881882, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005402', 'abnormal action potential', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881883, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002420', 'abnormal adaptive immunity', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881884, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881885, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013636', 'abnormal bone stiffness', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881886, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005088', 'increased acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881887, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008678', 'increased interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881888, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881889, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000231', 'hypertension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881890, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005410', 'abnormal fertilization', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881891, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030909', 'abnormal melanocyte adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881892, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001986', 'abnormal taste sensitivity', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881893, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010758', 'increased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881894, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010954', 'abnormal cellular respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881895, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010072', 'increased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881896, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008564', 'increased interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881897, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020039', 'increased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881898, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881899, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013637', 'increased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881900, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008721', 'abnormal chemokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881901, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881902, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031090', 'ageusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881903, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001912', 'increased cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881904, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010539', 'decreased level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881905, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013559', 'abnormal exocrine gland physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881906, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005085', 'abnormal gallbladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881907, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002164', 'abnormal gland physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881908, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004484', 'abnormal response of heart to induced stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881909, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013556', 'abnormal holocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881910, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881911, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010751', 'decreased susceptibility to parasitic infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881912, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881913, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008814', 'decreased nerve conduction velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881914, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003463', 'abnormal single cell response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881915, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001914', 'hemorrhage', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881916, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031051', 'lymph node hemorrhage', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881917, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881918, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003665', 'endophthalmitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881919, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881920, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001542', 'abnormal bone strength', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881921, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001853', 'heart inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881922, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001636', 'irregular heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881923, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003897', 'abnormal ST segment', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881924, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0014181', 'abnormal respiratory epithelial sodium ion transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881925, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003251', 'gallbladder inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881926, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031128', 'cardiovascular shunt', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881927, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006194', 'keratoconjunctivitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881928, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881929, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008544', 'impaired olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881930, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011046', 'abnormal lung tissue damping', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881931, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005001', 'abnormal clonal deletion', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881932, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004011', 'decreased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881933, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881934, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000316', 'cellular necrosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881935, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003746', 'stomatitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881936, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009643', 'abnormal urine homeostasis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881937, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003468', 'increased single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881938, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011399', 'increased endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881939, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010519', 'atrioventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881940, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881941, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010552', 'abnormal HV interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881942, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020371', 'abnormal glymphatic system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881943, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881944, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881945, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010393', 'shortened QRS complex duration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881946, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031247', 'decreased CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881947, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881948, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881949, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003725', 'increased autoantibody level', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881950, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009045', 'muscle tetany', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881951, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881952, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011936', 'abnormal PP interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881953, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006138', 'congestive heart failure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881954, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881955, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003899', 'abnormal QT interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881956, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031111', 'meningoencephalitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881957, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001194', 'dermatitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881958, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003454', 'erythroderma', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881959, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011953', 'prolonged PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881960, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881961, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031424', 'enhanced female fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881962, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009062', 'impaired lectin complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881963, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011012', 'bronchiectasis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881964, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881965, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003472', 'increased summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881966, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009789', 'decreased susceptibility to bacterial infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881967, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881968, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881969, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013627', 'increased vertebra yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881970, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003865', 'lymph node inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881971, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001337', 'dry eyes', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881972, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020000', 'abnormal response to antigen', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881973, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881974, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001752', 'abnormal hypothalamus secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881975, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001919', 'abnormal reproductive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881976, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000304', 'abnormal cardiac stroke volume', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881977, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031014', 'polyspermy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881978, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003659', 'abnormal lymph circulation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881979, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881980, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881981, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003926', 'decreased cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881982, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001876', 'decreased inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881983, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881984, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0021015', 'increased tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881985, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881986, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010994', 'aerophagia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881987, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012201', 'decreased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881988, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003467', 'abnormal single cell response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881989, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881990, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881991, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005251', 'blepharitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881992, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008943', 'increased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881993, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003898', 'abnormal QRS complex', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881994, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002499', 'chronic inflammation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881995, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881996, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011928', 'abnormal mitral valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881997, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003091', 'abnormal cell migration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(881998, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(881999, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001933', 'abnormal litter size', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882000, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001950', 'abnormal respiratory sounds', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882001, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001844', 'autoimmune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882002, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001841', 'decreased level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882003, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882004, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002419', 'abnormal innate immunity', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882005, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031241', 'decreased CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882006, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002500', 'granulomatous inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882007, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882008, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011937', 'shortened PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882009, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882010, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010513', 'abnormal ventricular activation time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882011, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002136', 'abnormal kidney physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882012, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882013, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010071', 'abnormal pruritus', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882014, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002842', 'increased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882015, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031425', 'enhanced male fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882016, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882017, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882018, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031402', 'decreased muscle fatigability', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882019, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010520', 'sinoatrial block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882020, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006080', 'brain ischemia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882021, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000327', 'hemosiderinuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882022, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882023, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002473', 'impaired complement classical pathway', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882024, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013475', 'delayed reproductive senescence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882025, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011418', 'leukocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882026, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001756', 'abnormal urination', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882027, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0014046', 'abnormal mitophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882028, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008748', 'abnormal central T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882029, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004211', 'abnormal sour taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882030, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005005', 'abnormal self tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882031, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005532', 'abnormal vascular resistance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882032, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020147', 'abnormal defecation amount', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882033, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882034, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008567', 'decreased interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882035, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012197', 'impaired myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882036, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000951', 'sporadic seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882037, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010695', 'abnormal blood pressure regulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882038, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004149', 'increased bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882039, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882040, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882041, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011718', 'decreased interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882042, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005275', 'abnormal skin tensile strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882043, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005043', 'defective assembly of class II molecules', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882044, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008775', 'abnormal heart ventricle pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882045, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882046, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003929', 'decreased heart rate variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882047, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020848', 'abnormal exocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882048, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882049, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008675', 'increased interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882050, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882051, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008697', 'decreased interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882052, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008003', 'achlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882053, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031129', 'left-to-right shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882054, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004512', 'anosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882055, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010750', 'increased susceptibility to parasitic infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882056, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882057, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882058, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882059, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882060, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882061, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882062, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882063, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882064, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882065, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031223', 'increased CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882066, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008995', 'early reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882067, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882068, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001854', 'atrial endocarditis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882069, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002330', 'abnormal bronchial provocation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882070, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002333', 'abnormal lung compliance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882071, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882072, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031053', 'pleuritis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882073, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004759', 'decreased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882074, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0021016', 'decreased tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882075, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001819', 'abnormal immune cell physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882076, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004036', 'abnormal muscle relaxation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882077, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002421', 'abnormal cell-mediated immunity', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882078, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003009', 'abnormal cytokine secretion', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882079, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006265', 'increased pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882080, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882081, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001873', 'stomach inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882082, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005645', 'abnormal hypothalamus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882083, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001921', 'reduced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882084, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882085, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003039', 'increased time of peak ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882086, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001761', 'abnormal urination pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882087, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031009', 'abnormal sperm-egg fusion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882088, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003123', 'paternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882089, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882090, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882091, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002106', 'abnormal muscle physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882092, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030129', 'tongue inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882093, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003252', 'abnormal bile duct physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882094, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011518', 'abnormal cell chemotaxis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882095, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003254', 'bile duct inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882096, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008413', 'decreased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882097, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002578', 'impaired ability to fire action potentials', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882098, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030990', 'nerve inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882099, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004782', 'abnormal surfactant physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882100, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003466', 'decreased single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882101, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002334', 'abnormal airway responsiveness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882102, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013498', 'trachea inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882103, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882104, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882105, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002254', 'reproductive system inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882106, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882107, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001851', 'eye inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882108, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008663', 'increased interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882109, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001945', 'bronchoconstriction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882110, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008412', 'increased cellular sensitivity to oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882111, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010560', 'intraventricular block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882112, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008562', 'increased interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882113, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031169', 'abnormal joint physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882114, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003261', 'hematemesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882115, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011465', 'abnormal urine urea nitrogen level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882116, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009661', 'abnormal pregnancy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882117, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006002', 'abnormal small intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882118, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882119, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004037', 'increased muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882120, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030130', 'gum inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882121, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030215', 'facial muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882122, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882123, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003233', 'prolonged QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882124, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003465', 'increased single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882125, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882126, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020845', 'abnormal DNA-templated transcription', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882127, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882128, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000738', 'impaired muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882129, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011805', 'decreased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882130, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882131, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003096', 'increased corneal light-scattering', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882132, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882133, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010636', 'bundle branch block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882134, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882135, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010680', 'abnormal skin adnexa physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882136, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001666', 'abnormal intestinal absorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882137, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003298', 'choking', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882138, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882139, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882140, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002935', 'chronic joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882141, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031092', 'dysgeusia', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882142, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013942', 'enthesitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882143, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008660', 'increased interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882144, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001845', 'abnormal inflammatory response', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882145, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882146, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000423', 'delayed hair regrowth', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882147, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882148, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012111', 'failure of morula compaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882149, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882150, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002635', 'reduced sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882151, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882152, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004142', 'abnormal muscle tone', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882153, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882154, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001840', 'increased level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882155, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012553', 'decreased serum complement activity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882156, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030153', 'dental pulp inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882157, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020218', 'abnormal tear production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882158, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006042', 'increased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882159, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008652', 'decreased interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882160, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008411', 'decreased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882161, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0021023', 'increased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882162, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031104', 'crackles', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882163, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008950', 'ventricular tachycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882164, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001951', 'abnormal breathing pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882165, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031089', 'sneezing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882166, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882167, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003787', 'abnormal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882168, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882169, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011931', 'abnormal pulmonary valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882170, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011013', 'bronchiolectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882171, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009058', 'decreased interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882172, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011194', 'abnormal hair follicle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882173, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882174, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003191', 'abnormal cellular cholesterol metabolism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882175, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008744', 'abnormal B cell anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882176, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011047', 'increased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882177, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882178, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001648', 'abnormal apoptosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882179, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008661', 'decreased interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882180, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003477', 'abnormal nerve fiber response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882181, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882182, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003280', 'urinary incontinence', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882183, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002498', 'abnormal acute inflammation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882184, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031013', 'abnormal egg activation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882185, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005004', 'abnormal lymphocyte anergy', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882186, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006336', 'abnormal otoacoustic response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882187, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008702', 'increased interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882188, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030988', 'dysosmia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882189, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008693', 'increased interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882190, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013640', 'increased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882191, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882192, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020080', 'increased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882193, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882194, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020414', 'abnormal fibroblast physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882195, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882196, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008877', 'abnormal DNA methylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882197, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005364', 'increased susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882198, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011938', 'prolonged PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882199, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006335', 'abnormal hearing electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882200, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000501', 'abnormal digestive secretion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882201, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882202, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013641', 'increased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882203, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882204, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000947', 'convulsive seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882205, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882206, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003882', 'abnormal pulse pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882207, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882208, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031482', 'abnormal urine hypoxanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882209, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882210, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031170', 'abnormal vasculature physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882211, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012556', 'increased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882212, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0014027', 'abnormal respiratory epithelial chloride transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882213, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008006', 'increased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882214, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001800', 'abnormal humoral immune response', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882215, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882216, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882217, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000503', 'excessive digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882218, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003889', 'enhanced sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882219, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003777', 'lip inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882220, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882221, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001984', 'abnormal olfaction', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882222, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004878', 'increased systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882223, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882224, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020096', 'high mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882225, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012120', 'trophectoderm cell degeneration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882226, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000352', 'decreased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882227, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003303', 'peritoneal inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882228, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010514', 'fragmented QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882229, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001837', 'defective assembly of class I molecules', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882230, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003340', 'acute pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882231, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013806', 'encephalopathy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882232, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882233, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008690', 'increased interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882234, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011420', 'pyuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882235, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003469', 'decreased single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882236, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882237, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882238, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011082', 'abnormal gastrointestinal motility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882239, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031054', 'bronchiolitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882240, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002626', 'increased heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882241, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882242, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031066', 'cytokine storm', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882243, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882244, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002405', 'respiratory system inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882245, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001934', 'increased litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882246, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010553', 'prolonged HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882247, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005621', 'abnormal cell physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882248, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882249, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030991', 'optic nerve inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882250, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001850', 'increased susceptibility to otitis media', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882251, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020001', 'decreased response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882252, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882253, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004877', 'abnormal systemic vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882254, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003762', 'abnormal immune organ physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882255, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882256, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882257, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000313', 'abnormal cell death', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882258, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005025', 'abnormal response to infection', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882259, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011954', 'shortened PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882260, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008861', 'abnormal hair shedding', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882261, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020137', 'decreased bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882262, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882263, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882264, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008666', 'increased interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882265, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0014241', 'abnormal intracellular organelle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882266, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011952', 'decreased cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882267, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010752', 'impaired mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882268, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012029', 'abnormal electroretinogram waveform feature', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882269, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002128', 'abnormal blood circulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882270, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882271, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008004', 'abnormal stomach pH', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882272, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008776', 'increased right ventricle peak pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882273, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002292', 'abnormal gestational length', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882274, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001947', 'abnormal mucociliary clearance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882275, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013459', 'perioral dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882276, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882277, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008750', 'abnormal interferon level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882278, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003880', 'abnormal central pattern generator function', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882279, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013625', 'increased femur yield load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882280, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009562', 'abnormal odor adaptation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882281, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010571', 'shortened ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882282, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002314', 'abnormal respiratory mechanics', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882283, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008664', 'decreased interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882284, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020155', 'enhanced humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882285, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004780', 'abnormal surfactant secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882286, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882287, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031086', 'wheezing', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882288, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882289, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008711', 'increased interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882290, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005501', 'abnormal skin physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882291, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008709', 'decreased interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882292, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005435', 'hemoperitoneum', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882293, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882294, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005576', 'decreased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882295, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008712', 'decreased interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882296, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0014037', 'stranguria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882297, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001835', 'abnormal antigen presentation', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882298, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011927', 'abnormal cardiac valve flow', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882299, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882300, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008751', 'abnormal interleukin level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882301, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0014042', 'decreased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882302, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882303, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882304, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882305, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010386', 'abnormal urinary bladder physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882306, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011043', 'abnormal lung elastance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882307, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006334', 'abnormal susceptibility to hearing loss', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882308, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008669', 'increased interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882309, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882310, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013639', 'decreased bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882311, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882312, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882313, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031088', 'coughing', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882314, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882315, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011918', 'abnormal PQ interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882316, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001664', 'abnormal digestion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882317, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020097', 'low mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882318, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882319, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002841', 'impaired skeletal muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882320, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020412', 'abnormal amnion physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882321, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013642', 'decreased vertebra stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882322, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001856', 'myocarditis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882323, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882324, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010155', 'abnormal intestine physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882325, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003394', 'increased cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882326, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001861', 'lung inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882327, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006082', 'CNS inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882328, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004879', 'decreased systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882329, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0021022', 'decreased adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882330, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882331, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001634', 'internal hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882332, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004947', 'skin inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882333, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882334, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003927', 'increased cellular glucose import', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882335, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001633', 'poor circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882336, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008260', 'abnormal autophagy', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882337, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013478', 'corneal limbitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882338, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882339, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011044', 'increased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882340, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009697', 'abnormal copulation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882341, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012011', 'febrile seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882342, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005333', 'decreased heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882343, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0014120', 'focal seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882344, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030940', 'impaired autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882345, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882346, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002896', 'abnormal bone mineralization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882347, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031105', 'rhonchi', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882348, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006001', 'abnormal intestinal transit time', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882349, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003122', 'maternal imprinting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882350, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011566', 'abnormal complement protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882351, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882352, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882353, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004213', 'abnormal umami taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882354, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020138', 'delayed bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882355, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002409', 'decreased susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882356, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004122', 'abnormal sinus arrhythmia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882357, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009790', 'decreased susceptibility to viral infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882358, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008008', 'early cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882359, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004145', 'abnormal muscle electrophysiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882360, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011431', 'increased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882361, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882362, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882363, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882364, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008007', 'abnormal cellular replicative senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882365, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031226', 'increased CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882366, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030214', 'muscle fasciculation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882367, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006190', 'retina ischemia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882368, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005423', 'abnormal somatic nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882369, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001627', 'abnormal cardiac output', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882370, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882371, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006114', 'cardiac murmur', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882372, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003560', 'osteoarthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882373, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020381', 'muscle gating pore current', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882374, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011764', 'ureteritis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882375, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013557', 'abnormal merocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882376, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011432', 'decreased urine flow rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882377, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010570', 'prolonged ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882378, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001793', 'abnormal susceptibility to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882379, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882380, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882381, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011925', 'abnormal heart echocardiography feature', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882382, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882383, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882384, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882385, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000343', 'abnormal response to cardiac infarction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882386, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013644', 'increased vertebra maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882387, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030951', 'abnormal endocytosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882388, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882389, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001533', 'abnormal skeleton physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882390, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003866', 'abnormal defecation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882391, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882392, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882393, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010394', 'decreased QRS amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882394, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004143', 'muscle hypertonia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882395, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011717', 'increased interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882396, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882397, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882398, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004227', 'increased cellular sensitivity to ionizing radiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882399, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882400, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882401, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882402, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031095', 'pharyngitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882403, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031127', 'dry gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882404, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004010', 'increased diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882405, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0014132', 'abnormal tear film physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882406, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001663', 'abnormal digestive system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882407, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003471', 'abnormal summary potential threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882408, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009057', 'increased interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882409, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882410, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001596', 'hypotension', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882411, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010922', 'alveolitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882412, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003481', 'decreased nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882413, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882414, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004558', 'delayed allantois development', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882415, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008565', 'decreased interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882416, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031470', 'abnormal macropinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882417, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003157', 'impaired muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882418, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003621', 'dysuria', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882419, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0014040', 'increased cellular sensitivity to DNA damaging agents', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882420, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882421, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882422, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001954', 'respiratory distress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882423, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010896', 'decreased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882424, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882425, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882426, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011900', 'podocyturia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882427, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882428, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009344', 'abnormal ovulation cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882429, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005253', 'abnormal eye physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882430, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002987', 'abnormal urine osmolality', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882431, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003470', 'abnormal summary potential', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882432, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003292', 'melena', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882433, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003925', 'abnormal cellular glucose uptake', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882434, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004945', 'abnormal bone resorption', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882435, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882436, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882437, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009645', 'crystalluria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882438, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006049', 'semilunar valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882439, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010504', 'abnormal RR interval', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882440, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006266', 'decreased pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882441, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882442, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008708', 'increased interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882443, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002418', 'increased susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882444, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882445, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882446, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882447, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008555', 'abnormal interferon secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882448, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012554', 'increased serum complement activity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882449, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882450, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003900', 'shortened QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882451, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011809', 'abnormal anoikis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882452, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002064', 'seizures', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882453, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008817', 'hematoma', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882454, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882455, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882456, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882457, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003476', 'decreased summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882458, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013752', 'stridor', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882459, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003306', 'small intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882460, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002322', 'abnormal respiratory transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882461, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011048', 'decreased lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882462, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009348', 'abnormal urine pH', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882463, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009357', 'abnormal seizure response to inducing agent', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882464, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020846', 'abnormal cell motility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882465, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031471', 'abnormal micropinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882466, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882467, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001943', 'abnormal respiration', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882468, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011763', 'urethritis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882469, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882470, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882471, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013971', 'blood in lymph vessels', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882472, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030924', 'early exit from telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882473, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009698', 'heart hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882474, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012745', 'abnormal neural crest cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882475, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004009', 'abnormal diastolic filling velocity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882476, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011219', 'abnormal intestinal calcium absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882477, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001935', 'decreased litter size', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882478, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010950', 'abnormal lung hysteresivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882479, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001924', 'infertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882480, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002296', 'aspiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882481, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001858', 'intestinal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882482, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031102', 'rhinorrhea', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882483, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008942', 'abnormal induced cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882484, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011919', 'abnormal R wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882485, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009732', 'ventricular premature beat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882486, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031098', 'abnormal sputum production', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882487, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882488, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008687', 'increased interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882489, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008272', 'abnormal endochondral bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882490, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0014274', 'decreased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882491, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003412', 'abnormal afterhyperpolarization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882492, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008713', 'abnormal cytokine level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882493, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882494, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882495, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003901', 'abnormal PR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882496, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882497, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005044', 'sepsis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882498, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882499, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882500, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001866', 'nasal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882501, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882502, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882503, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010559', 'heart block', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882504, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005036', 'diarrhea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882505, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004796', 'increased anti-histone antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882506, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002161', 'abnormal fertility/fecundity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882507, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008568', 'abnormal interleukin secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882508, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005087', 'decreased acute inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882509, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003341', 'chronic pancreas inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882510, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010073', 'decreased pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882511, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031055', 'bronchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882512, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010377', 'abnormal gut flora balance', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882513, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010554', 'shortened HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882514, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011762', 'renal/urinary system inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882515, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882516, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882517, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003482', 'increased nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882518, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031469', 'abnormal pinocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882519, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020154', 'impaired humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882520, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882521, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020002', 'increased response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882522, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012610', 'increased complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882523, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008684', 'increased interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882524, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008002', 'hyperchlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882525, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030938', 'abnormal reticulophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882526, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001862', 'interstitial pneumonia', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882527, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012608', 'abnormal complement C5 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882528, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013632', 'increased femur maximal load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882529, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006276', 'abnormal autonomic nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882530, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882531, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030939', 'abnormal autophagosome formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882532, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031225', 'decreased CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882533, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008009', 'delayed cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882534, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004046', 'abnormal mitosis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882535, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882536, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003726', 'decreased autoantibody level', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882537, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882538, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882539, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882540, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004144', 'hypotonia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882541, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882542, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013479', 'scleritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882543, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882544, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003566', 'abnormal cell adhesion', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882545, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003483', 'decreased nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882546, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882547, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002325', 'abnormal pulmonary diffusing capacity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882548, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009792', 'seborrheic dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882549, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002406', 'increased susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882550, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008679', 'decreased interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882551, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008737', 'abnormal spleen physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882552, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031222', 'decreased CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882553, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882554, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882555, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882556, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882557, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005037', 'mucous diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882558, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882559, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011930', 'abnormal tricuspid valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882560, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882561, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003767', 'palate inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882562, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009384', 'cardiac valve regurgitation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882563, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882564, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003475', 'increased summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882565, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008696', 'increased interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882566, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031242', 'increased CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882567, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013135', 'poor circulation in tail', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882568, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003480', 'increased nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882569, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004742', 'abnormal vestibular system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882570, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010143', 'enhanced fertility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882571, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031130', 'right-to-left shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882572, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882573, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008539', 'decreased susceptibility to induced colitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882574, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008681', 'increased interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882575, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010992', 'increased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882576, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008722', 'abnormal chemokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882577, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882578, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011926', 'abnormal heart valve physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882579, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004781', 'abnormal surfactant composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882580, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003474', 'abnormal summary potential intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882581, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882582, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030216', 'tongue muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882583, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008672', 'increased interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882584, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003868', 'abnormal feces composition', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882585, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003186', 'abnormal redox activity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882586, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009046', 'muscle twitch', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882587, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000740', 'impaired smooth muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882588, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882589, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0014195', 'abnormal endocrine pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882590, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004031', 'insulitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882591, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009275', 'bruising', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882592, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001846', 'increased inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882593, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882594, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013555', 'abnormal apocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882595, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882596, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882597, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000743', 'muscle spasm', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882598, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000427', 'abnormal hair cycle', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882599, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010634', 'increased QRS amplitude', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882600, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008700', 'decreased interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882601, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002693', 'abnormal pancreas physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882602, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882603, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004005', 'impaired contractility of intestinal smooth muscle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882604, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003393', 'decreased cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882605, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003464', 'abnormal single cell response threshold', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882606, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008673', 'decreased interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882607, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882608, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882609, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004085', 'abnormal heartbeat', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882610, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006003', 'abnormal large intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882611, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009567', 'mitotic nondisjunction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882612, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001963', 'abnormal hearing physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882613, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882614, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882615, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882616, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001665', 'chronic diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882617, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030941', 'enhanced autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882618, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020040', 'decreased bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882619, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882620, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005190', 'osteomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882621, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001313', 'increased incidence of corneal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882622, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030132', 'periodontium inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882623, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003698', 'abnormal male reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882624, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003823', 'increased left ventricle developed pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882625, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882626, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011994', 'increased nerve conduction velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882627, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882628, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012006', 'abnormal hippocampus physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882629, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031306', 'abnormal cartilage physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882630, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008703', 'decreased interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882631, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003741', 'tinnitus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882632, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013145', 'eye discharge', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882633, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001849', 'ear inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882634, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002998', 'abnormal bone remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882635, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000751', 'myopathy', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882636, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004212', 'abnormal salty taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882637, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001864', 'vascular inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882638, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000505', 'decreased digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882639, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013561', 'abnormal endocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882640, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004510', 'myositis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882641, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010741', 'abnormal melanocyte proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882642, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012382', 'abnormal blood cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882643, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003674', 'oxidative stress', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882644, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008410', 'increased cellular sensitivity to ultraviolet irradiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882645, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031480', 'abnormal urine xanthine level', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882646, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003875', 'abnormal hair follicle regression', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882647, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001852', 'conjunctivitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882648, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882649, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001913', 'decreased cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882650, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008699', 'increased interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882651, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882652, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005580', 'periinsulitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882653, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000350', 'abnormal cell proliferation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882654, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005551', 'abnormal eye electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882655, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003116', 'rickets', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882656, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001847', 'brain inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882657, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882658, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031125', 'aspiration pneumonia', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882659, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010993', 'decreased surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882660, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882661, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003878', 'abnormal ear physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882662, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882663, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002133', 'abnormal respiratory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882664, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882665, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882666, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882667, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003547', 'abnormal pulmonary pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882668, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882669, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002327', 'abnormal respiratory function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882670, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002993', 'arthritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882671, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009762', 'abnormal mitotic spindle assembly checkpoint', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882672, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882673, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882674, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010028', 'aciduria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882675, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004751', 'increased length of allograft survival', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882676, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0014275', 'increased respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882677, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001629', 'abnormal heart rate', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882678, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882679, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011804', 'increased cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882680, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882681, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005000', 'abnormal immune tolerance', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882682, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882683, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882684, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003260', 'vomiting', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882685, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008271', 'abnormal bone ossification', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882686, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882687, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030822', 'sacroiliac joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882688, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004994', 'abnormal brain wave pattern', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882689, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882690, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008682', 'decreased interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882691, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882692, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008670', 'decreased interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882693, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011164', 'panniculitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882694, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882695, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009791', 'increased susceptibility to viral infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882696, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006043', 'decreased apoptosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882697, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882698, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012200', 'increased endothelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882699, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002472', 'impaired complement alternative pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882700, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008566', 'increased interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882701, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010538', 'increased level of surface class II molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882702, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003259', 'nausea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882703, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004760', 'increased mitotic index', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882704, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882705, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003011', 'delayed dark adaptation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882706, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008706', 'decreased interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882707, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882708, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008005', 'decreased stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882709, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001872', 'sinus inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882710, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008705', 'increased interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882711, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002328', 'abnormal airway resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882712, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882713, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010381', 'abnormal dosage compensation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882714, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012685', 'abnormal primitive streak elongation', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882715, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010637', 'sinus bradycardia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882716, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003820', 'increased left ventricle systolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882717, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005666', 'abnormal adipose tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882718, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013460', 'periocular dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882719, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882720, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010756', 'decreased right ventricle peak pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882721, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008688', 'decreased interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882722, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003699', 'abnormal female reproductive system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882723, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020386', 'adipose tissue inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882724, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001983', 'abnormal olfactory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882725, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882726, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002338', 'abnormal pulmonary ventilation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882727, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005575', 'increased pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882728, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882729, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020142', 'increased anti-sperm antibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882730, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011920', 'abnormal S wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882731, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882732, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882733, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004072', 'abnormal frontal plane axis', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882734, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010753', 'improved mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882735, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003304', 'large intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882736, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010515', 'abnormal Q wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882737, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882738, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003077', 'abnormal cell cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882739, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008676', 'decreased interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882740, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013634', 'increased femur fracture load', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882741, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003633', 'abnormal nervous system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882742, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002634', 'abnormal sensorimotor gating', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882743, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882744, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004070', 'abnormal P wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882745, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882746, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882747, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008685', 'decreased interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882748, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882749, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002934', 'acute joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882750, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882751, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013136', 'genital discharge', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882752, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031302', 'syncope', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882753, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005403', 'abnormal nerve conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882754, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009788', 'increased susceptibility to bacterial infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882755, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882756, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031246', 'abnormal CCL3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882757, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008563', 'decreased interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882758, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882759, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882760, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882761, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001867', 'rhinitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882762, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001790', 'abnormal immune system physiology', 0.6086956521739131, 7.400946880077414, 2.122480668433333, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882763, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011421', 'cylindruria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882764, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004752', 'decreased length of allograft survival', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882765, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010957', 'abnormal aerobic respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882766, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030573', 'abnormal hair follicle cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882767, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009473', 'abnormal skin exfoliation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882768, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001985', 'abnormal gustatory system physiology', 0.5, 5.059610039003922, 1.5905360792833216, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882769, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012609', 'decreased complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882770, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011045', 'decreased lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882771, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005076', 'abnormal cell differentiation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882772, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002694', 'abnormal pancreas secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882773, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882774, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003928', 'increased heart rate variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882775, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0021009', 'abnormal synaptic physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882776, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031091', 'hypogeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882777, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008651', 'increased interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882778, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882779, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010505', 'abnormal T wave', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882780, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031224', 'abnormal CXCL10 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882781, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031110', 'meningitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882782, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882783, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882784, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012565', 'perivasculitis', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882785, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030118', 'rhinosinusitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882786, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013208', 'abnormal cilium physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882787, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005671', 'abnormal response to transplant', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882788, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001869', 'pancreas inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882789, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882790, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011929', 'abnormal aortic valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882791, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003278', 'esophageal inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882792, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882793, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010211', 'abnormal acute phase protein level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882794, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002933', 'joint inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882795, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008691', 'decreased interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882796, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003824', 'decreased left ventricle developed pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882797, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0030987', 'spinal cord inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882798, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882799, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000351', 'increased cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882800, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002090', 'abnormal vision', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882801, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882802, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882803, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0002999', 'abnormal bone healing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882804, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005620', 'abnormal muscle contractility', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882805, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0013638', 'decreased femur stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882806, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031240', 'abnormal CSF3 level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882807, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0005515', 'uveitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882808, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0000948', 'nonconvulsive seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882809, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0003473', 'decreased summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882810, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031248', 'increased CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882811, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0031126', 'gangrene', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882812, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0006046', 'atrioventricular valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882813, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010946', 'hyperpnea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882814, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010822', 'pneumothorax', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882815, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0011951', 'increased cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882816, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001857', 'pericarditis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882817, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882818, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0001598', 'abnormal blood viscosity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882819, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0010895', 'increased lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882820, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0008001', 'hypochlorhydria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882821, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0009247', 'meteorism', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882822, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0004156', 'abnormal QT variability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882823, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012555', 'decreased cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882824, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882825, 'HP:0031390', 'Reduced MHC II surface expression', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(882826, 'HP:0032163', 'Molluscum contagiosum', 'MP:0002499', 'chronic inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882827, 'HP:0032163', 'Molluscum contagiosum', 'MP:0005025', 'abnormal response to infection', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882828, 'HP:0032163', 'Molluscum contagiosum', 'MP:0001835', 'abnormal antigen presentation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882829, 'HP:0032163', 'Molluscum contagiosum', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42105263157894735, 7.400946880077414, 1.7652728287810344, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882830, 'HP:0032163', 'Molluscum contagiosum', 'MP:0005000', 'abnormal immune tolerance', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882831, 'HP:0032163', 'Molluscum contagiosum', 'MP:0002471', 'abnormal complement pathway', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882832, 'HP:0032163', 'Molluscum contagiosum', 'MP:0003009', 'abnormal cytokine secretion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882833, 'HP:0032163', 'Molluscum contagiosum', 'MP:0009473', 'abnormal skin exfoliation', 0.42424242424242425, 6.904974582545727, 1.7115440853894242, 'UPHENO:0003811', 'abnormal skin of body'),
(882834, 'HP:0032163', 'Molluscum contagiosum', 'MP:0001194', 'dermatitis', 0.42105263157894735, 7.400946880077414, 1.7652728287810344, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882835, 'HP:0032163', 'Molluscum contagiosum', 'MP:0009792', 'seborrheic dermatitis', 0.41025641025641024, 7.400946880077414, 1.7424941605408435, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882836, 'HP:0032163', 'Molluscum contagiosum', 'MP:0005275', 'abnormal skin tensile strength', 0.42424242424242425, 6.904974582545727, 1.7115440853894242, 'UPHENO:0003811', 'abnormal skin of body'),
(882837, 'HP:0032163', 'Molluscum contagiosum', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882838, 'HP:0032163', 'Molluscum contagiosum', 'MP:0003762', 'abnormal immune organ physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882839, 'HP:0032163', 'Molluscum contagiosum', 'MP:0004752', 'decreased length of allograft survival', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882840, 'HP:0032163', 'Molluscum contagiosum', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882841, 'HP:0032163', 'Molluscum contagiosum', 'MP:0001793', 'abnormal susceptibility to infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882842, 'HP:0032163', 'Molluscum contagiosum', 'MP:0002723', 'abnormal immune serum protein physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882843, 'HP:0032163', 'Molluscum contagiosum', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882844, 'HP:0032163', 'Molluscum contagiosum', 'MP:0005001', 'abnormal clonal deletion', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882845, 'HP:0032163', 'Molluscum contagiosum', 'MP:0030153', 'dental pulp inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882846, 'HP:0032163', 'Molluscum contagiosum', 'MP:0005671', 'abnormal response to transplant', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882847, 'HP:0032163', 'Molluscum contagiosum', 'MP:0020154', 'impaired humoral immune response', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882848, 'HP:0032163', 'Molluscum contagiosum', 'MP:0002420', 'abnormal adaptive immunity', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882849, 'HP:0032163', 'Molluscum contagiosum', 'MP:0008568', 'abnormal interleukin secretion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882850, 'HP:0032163', 'Molluscum contagiosum', 'MP:0010368', 'abnormal lymphatic system physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882851, 'HP:0032163', 'Molluscum contagiosum', 'MP:0001800', 'abnormal humoral immune response', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882852, 'HP:0032163', 'Molluscum contagiosum', 'MP:0002498', 'abnormal acute inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882853, 'HP:0032163', 'Molluscum contagiosum', 'MP:0020155', 'enhanced humoral immune response', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882854, 'HP:0032163', 'Molluscum contagiosum', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882855, 'HP:0032163', 'Molluscum contagiosum', 'MP:0013459', 'perioral dermatitis', 0.41025641025641024, 7.400946880077414, 1.7424941605408435, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882856, 'HP:0032163', 'Molluscum contagiosum', 'MP:0010071', 'abnormal pruritus', 0.42424242424242425, 6.904974582545727, 1.7115440853894242, 'UPHENO:0003811', 'abnormal skin of body'),
(882857, 'HP:0032163', 'Molluscum contagiosum', 'MP:0005501', 'abnormal skin physiology', 0.4375, 6.904974582545727, 1.7380812351164014, 'UPHENO:0003811', 'abnormal skin of body'),
(882858, 'HP:0032163', 'Molluscum contagiosum', 'MP:0008744', 'abnormal B cell anergy', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882859, 'HP:0032163', 'Molluscum contagiosum', 'MP:0003454', 'erythroderma', 0.41025641025641024, 7.400946880077414, 1.7424941605408435, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882860, 'HP:0032163', 'Molluscum contagiosum', 'MP:0020001', 'decreased response to antigen', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882861, 'HP:0032163', 'Molluscum contagiosum', 'MP:0030132', 'periodontium inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882862, 'HP:0032163', 'Molluscum contagiosum', 'MP:0002500', 'granulomatous inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882863, 'HP:0032163', 'Molluscum contagiosum', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882864, 'HP:0032163', 'Molluscum contagiosum', 'MP:0005005', 'abnormal self tolerance', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882865, 'HP:0032163', 'Molluscum contagiosum', 'MP:0030129', 'tongue inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882866, 'HP:0032163', 'Molluscum contagiosum', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882867, 'HP:0032163', 'Molluscum contagiosum', 'MP:0001790', 'abnormal immune system physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882868, 'HP:0032163', 'Molluscum contagiosum', 'MP:0001846', 'increased inflammatory response', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882869, 'HP:0032163', 'Molluscum contagiosum', 'MP:0001837', 'defective assembly of class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882870, 'HP:0032163', 'Molluscum contagiosum', 'MP:0001876', 'decreased inflammatory response', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882871, 'HP:0032163', 'Molluscum contagiosum', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882872, 'HP:0032163', 'Molluscum contagiosum', 'MP:0005044', 'sepsis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882873, 'HP:0032163', 'Molluscum contagiosum', 'MP:0001845', 'abnormal inflammatory response', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882874, 'HP:0032163', 'Molluscum contagiosum', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882875, 'HP:0032163', 'Molluscum contagiosum', 'MP:0003777', 'lip inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882876, 'HP:0032163', 'Molluscum contagiosum', 'MP:0008722', 'abnormal chemokine secretion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882877, 'HP:0032163', 'Molluscum contagiosum', 'MP:0001844', 'autoimmune response', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882878, 'HP:0032163', 'Molluscum contagiosum', 'MP:0008555', 'abnormal interferon secretion', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882879, 'HP:0032163', 'Molluscum contagiosum', 'MP:0011194', 'abnormal hair follicle physiology', 0.4117647058823529, 6.904974582545727, 1.686186474891512, 'UPHENO:0003811', 'abnormal skin of body'),
(882880, 'HP:0032163', 'Molluscum contagiosum', 'MP:0004947', 'skin inflammation', 0.43243243243243246, 7.400946880077414, 1.788968826350839, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882881, 'HP:0032163', 'Molluscum contagiosum', 'MP:0010072', 'increased pruritus', 0.4117647058823529, 6.904974582545727, 1.686186474891512, 'UPHENO:0003811', 'abnormal skin of body'),
(882882, 'HP:0032163', 'Molluscum contagiosum', 'MP:0020000', 'abnormal response to antigen', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882883, 'HP:0032163', 'Molluscum contagiosum', 'MP:0008747', 'abnormal T cell anergy', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882884, 'HP:0032163', 'Molluscum contagiosum', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42105263157894735, 7.400946880077414, 1.7652728287810344, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882885, 'HP:0032163', 'Molluscum contagiosum', 'MP:0005004', 'abnormal lymphocyte anergy', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882886, 'HP:0032163', 'Molluscum contagiosum', 'MP:0010073', 'decreased pruritus', 0.4117647058823529, 6.904974582545727, 1.686186474891512, 'UPHENO:0003811', 'abnormal skin of body'),
(882887, 'HP:0032163', 'Molluscum contagiosum', 'MP:0002419', 'abnormal innate immunity', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882888, 'HP:0032163', 'Molluscum contagiosum', 'MP:0005043', 'defective assembly of class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882889, 'HP:0032163', 'Molluscum contagiosum', 'MP:0012565', 'perivasculitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882890, 'HP:0032163', 'Molluscum contagiosum', 'MP:0020002', 'increased response to antigen', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882891, 'HP:0032163', 'Molluscum contagiosum', 'MP:0002421', 'abnormal cell-mediated immunity', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882892, 'HP:0032163', 'Molluscum contagiosum', 'MP:0004751', 'increased length of allograft survival', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(882893, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0002903', 'abnormal circulating parathyroid hormone level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882894, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0012328', 'decreased circulating factor VIII level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882895, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0004700', 'abnormal circulating insulin-like growth factor I level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882896, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031340', 'abnormal circulating lipocalin 2 level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882897, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0012223', 'increased circulating prothrombin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882898, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0021035', 'decreased circulating cartilage oligomeric matrix protein level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882899, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0021034', 'abnormal circulating cartilage oligomeric matrix protein level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(882900, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0012666', 'increased circulating haptoglobin level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(882901, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0011891', 'decreased circulating ferritin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882902, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0012329', 'increased circulating factor VIII level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882903, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0002965', 'increased circulating serum albumin level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882904, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0009699', 'hyperchylomicronemia', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882905, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0012326', 'increased circulating antithrombin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882906, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0013256', 'increased circulating thrombin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882907, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031073', 'decreased circulating type I collagen C-terminal telopeptide level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882908, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0012324', 'abnormal circulating antithrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(882909, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0010216', 'abnormal circulating retinol binding protein level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(882910, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0020256', 'abnormal circulating factor XII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(882911, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031164', 'decreased circulating von Willebrand factor level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882912, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0005667', 'abnormal circulating leptin level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882913, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0005521', 'abnormal circulating atrial natriuretic factor level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882914, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0012222', 'decreased circulating prothrombin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882915, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0001573', 'abnormal circulating alanine transaminase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882916, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0005265', 'abnormal blood urea nitrogen level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(882917, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0003349', 'abnormal circulating renin level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882918, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0012664', 'decreased circulating haptoglobin level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(882919, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031114', 'increased circulating gamma-glutamyl transferase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(882920, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0005419', 'decreased circulating serum albumin level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882921, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0020983', 'abnormal circulating factor XI level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(882922, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0020986', 'abnormal circulating ceruloplasmin level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(882923, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0012221', 'abnormal circulating prothrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(882924, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031079', 'increased circulating troponin I level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(882925, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0001560', 'abnormal circulating insulin level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882926, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0005632', 'decreased circulating aspartate transaminase level', 0.4230769230769231, 8.670509328908704, 1.9152786764292167, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882927, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0013257', 'decreased circulating thrombin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882928, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0012325', 'decreased circulating antithrombin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882929, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0008820', 'abnormal blood uric acid level', 0.41304347826086957, 8.001050554100775, 1.8179058695671901, 'UPHENO:0077826', 'abnormal blood nitrogen molecular entity level'),
(882930, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031075', 'abnormal circulating troponin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(882931, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031082', 'decreased circulating D-dimer level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882932, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0012617', 'abnormal circulating factor X level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(882933, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0000202', 'abnormal circulating alkaline phosphatase level', 0.4230769230769231, 8.670509328908704, 1.9152786764292167, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882934, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031076', 'decreased circulating troponin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882935, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0000199', 'abnormal circulating serum albumin level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882936, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031078', 'increased circulating troponin T level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(882937, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0001570', 'abnormal circulating enzyme level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882938, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031108', 'increased circulating myoglobin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882939, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0011888', 'abnormal circulating total protein level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(882940, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0011008', 'abnormal circulating glutamate dehydrogenase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882941, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0012333', 'increased circulating fibronectin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882942, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031065', 'increased circulating procalcitonin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882943, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031107', 'abnormal circulating myoglobin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(882944, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0020246', 'abnormal circulating arginase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(882945, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031074', 'increased circulating type I collagen C-terminal telopeptide level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882946, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0011889', 'abnormal circulating ferritin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(882947, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031083', 'increased circulating D-dimer level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882948, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0005416', 'abnormal circulating protein level', 0.43478260869565216, 8.144985856518405, 1.881833732954711, 'UPHENO:0046362', 'abnormal protein level'),
(882949, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031163', 'abnormal circulating von Willebrand factor level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(882950, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0011890', 'increased circulating ferritin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882951, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0002695', 'abnormal circulating glucagon level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882952, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031081', 'abnormal circulating D-dimer level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(882953, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0012332', 'decreased circulating fibronectin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882954, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0013255', 'abnormal circulating thrombin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(882955, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0011894', 'decreased circulating transferrin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882956, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0010106', 'abnormal circulating pyruvate kinase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(882957, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0012614', 'abnormal circulating factor IX level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(882958, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0010332', 'abnormal circulating apolipoprotein level', 0.4230769230769231, 8.670509328908704, 1.9152786764292167, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882959, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0011892', 'abnormal circulating transferrin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(882960, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0010330', 'abnormal circulating lipoprotein level', 0.4489795918367347, 8.670509328908704, 1.973038707048098, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882961, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0008459', 'abnormal circulating pancreatic peptide level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882962, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0002942', 'decreased circulating alanine transaminase level', 0.4230769230769231, 8.670509328908704, 1.9152786764292167, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882963, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0011284', 'abnormal circulating erythropoietin level', 0.44, 8.670509328908704, 1.9532086690161474, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882964, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0021036', 'increased circulating cartilage oligomeric matrix protein level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882965, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0012620', 'abnormal circulating factor XIII level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(882966, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0008804', 'abnormal circulating amylase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(882967, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0006373', 'abnormal circulating angiotensinogen level', 0.4230769230769231, 8.670509328908704, 1.9152786764292167, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882968, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031165', 'increased circulating von Willebrand factor level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882969, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0011912', 'abnormal circulating fibronectin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(882970, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0012327', 'abnormal circulating factor VIII level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(882971, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0011895', 'abnormal circulating unsaturated transferrin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882972, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0011893', 'increased circulating transferrin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882973, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0002941', 'increased circulating alanine transaminase level', 0.4230769230769231, 8.670509328908704, 1.9152786764292167, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882974, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031072', 'abnormal circulating type I collagen C-terminal telopeptide level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(882975, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031077', 'increased circulating troponin level', 0.4166666666666667, 8.144985856518405, 1.8422117432267846, 'UPHENO:0046362', 'abnormal protein level'),
(882976, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0031064', 'abnormal circulating procalcitonin level', 0.425531914893617, 8.144985856518405, 1.861706590283685, 'UPHENO:0046362', 'abnormal protein level'),
(882977, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0011885', 'abnormal circulating lipase level', 0.40816326530612246, 8.144985856518405, 1.823316764325041, 'UPHENO:0046362', 'abnormal protein level'),
(882978, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0004730', 'abnormal circulating gastrin level', 0.4583333333333333, 8.670509328908704, 1.9934852501125984, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882979, 'HP:0410193', 'Abnormal uridine diphosphate glucose-4-epimerase level in plasma', 'MP:0000203', 'abnormal circulating aspartate transaminase level', 0.43137254901960786, 8.670509328908704, 1.9339647645470786, 'UPHENO:0051936', 'abnormal independent continuant protein level'),
(882980, 'HP:0008467', 'Thoracic hemivertebrae', 'MP:0000459', 'abnormal presacral vertebrae morphology', 0.4146341463414634, 8.941811350726098, 1.9255078073471226, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(882981, 'HP:0008467', 'Thoracic hemivertebrae', 'MP:0004669', 'enlarged vertebral body', 0.4444444444444444, 10.93472192593978, 2.2045127378921605, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(882982, 'HP:0008467', 'Thoracic hemivertebrae', 'MP:0004626', 'vertebral compression', 0.40425531914893614, 8.941811350726098, 1.9012561114582536, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(882983, 'HP:0008467', 'Thoracic hemivertebrae', 'MP:0000141', 'abnormal vertebral body morphology', 0.425, 10.93472192593978, 2.1557497114749675, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(882984, 'HP:0008467', 'Thoracic hemivertebrae', 'MP:0004670', 'small vertebral body', 0.43478260869565216, 10.93472192593978, 2.1804189790775634, 'UPHENO:0076707', 'abnormal bony vertebral centrum morphology'),
(882985, 'HP:0008467', 'Thoracic hemivertebrae', 'MP:0004610', 'small vertebrae', 0.4318181818181818, 8.941811350726098, 1.9650029820923236, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(882986, 'HP:0008467', 'Thoracic hemivertebrae', 'MP:0021136', 'abnormal vertebrae shape', 0.4222222222222222, 8.941811350726098, 1.943046952390874, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(882987, 'HP:0008467', 'Thoracic hemivertebrae', 'MP:0021137', 'abnormal wedge-shaped vertebrae', 0.41304347826086957, 8.941811350726098, 1.9218108289466038, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(882988, 'HP:0008467', 'Thoracic hemivertebrae', 'MP:0000137', 'abnormal vertebrae morphology', 0.41025641025641024, 8.941811350726098, 1.9153160120301067, 'UPHENO:0076744', 'abnormal vertebra morphology'),
(882989, 'HP:0040145', 'Dicarboxylic acidemia', 'MP:0030630', 'increased circulating methylmalonic acid level', 0.43037974683544306, 13.944182255188847, 2.449753789427716, 'UPHENO:0080639', 'increased level of dicarboxylic acid in blood'),
(882990, 'HP:0040145', 'Dicarboxylic acidemia', 'MP:0005344', 'increased circulating bilirubin level', 0.41975308641975306, 13.944182255188847, 2.419320883887681, 'UPHENO:0080639', 'increased level of dicarboxylic acid in blood'),
(882991, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0020836', 'increased circulating citrulline level', 0.4215686274509804, 10.437222266468963, 2.0976189990739815, 'UPHENO:0082543', 'increased bodily fluid acid level'),
(882992, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0030694', 'increased circulating serine level', 0.41346153846153844, 10.437222266468963, 2.077351673539962, 'UPHENO:0082543', 'increased bodily fluid acid level'),
(882993, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0030673', 'increased circulating alanine level', 0.43, 10.437222266468963, 2.1184913439949793, 'UPHENO:0082543', 'increased bodily fluid acid level'),
(882994, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0030709', 'increased circulating glutamine level', 0.41346153846153844, 10.437222266468963, 2.077351673539962, 'UPHENO:0082543', 'increased bodily fluid acid level'),
(882995, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0030655', 'increased circulating glycine level', 0.4056603773584906, 10.437222266468963, 2.057660691948563, 'UPHENO:0082543', 'increased bodily fluid acid level'),
(882996, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0030718', 'increased circulating lysine level', 0.4095238095238095, 10.437222266468963, 2.0674358571455365, 'UPHENO:0082543', 'increased bodily fluid acid level'),
(882997, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0030739', 'increased circulating glutamic acid level', 0.41346153846153844, 10.437222266468963, 2.077351673539962, 'UPHENO:0082543', 'increased bodily fluid acid level'),
(882998, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0030687', 'increased circulating cystathionine level', 0.4056603773584906, 10.437222266468963, 2.057660691948563, 'UPHENO:0082543', 'increased bodily fluid acid level'),
(882999, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0030644', 'increased circulating methionine level', 0.41346153846153844, 10.437222266468963, 2.077351673539962, 'UPHENO:0082543', 'increased bodily fluid acid level'),
(883000, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0030650', 'increased circulating ornithine level', 0.4056603773584906, 10.437222266468963, 2.057660691948563, 'UPHENO:0082543', 'increased bodily fluid acid level'),
(883001, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0030667', 'increased circulating proline level', 0.41346153846153844, 10.437222266468963, 2.077351673539962, 'UPHENO:0082543', 'increased bodily fluid acid level'),
(883002, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0030703', 'increased circulating threonine level', 0.41346153846153844, 10.437222266468963, 2.077351673539962, 'UPHENO:0082543', 'increased bodily fluid acid level'),
(883003, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0012335', 'increased circulating homocysteine level', 0.4215686274509804, 10.437222266468963, 2.0976189990739815, 'UPHENO:0082543', 'increased bodily fluid acid level'),
(883004, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0011652', 'increased circulating histidine level', 0.44, 11.799792345853673, 2.278576009742843, 'UPHENO:0052010', 'abnormal independent continuant aromatic amino acid level'),
(883005, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0030715', 'increased circulating isoleucine level', 0.4056603773584906, 10.437222266468963, 2.057660691948563, 'UPHENO:0082543', 'increased bodily fluid acid level'),
(883006, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0013723', 'increased circulating tyrosine level', 0.44, 11.799792345853673, 2.278576009742843, 'UPHENO:0052010', 'abnormal independent continuant aromatic amino acid level'),
(883007, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0030750', 'increased circulating leucine level', 0.4056603773584906, 10.437222266468963, 2.057660691948563, 'UPHENO:0082543', 'increased bodily fluid acid level'),
(883008, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0030727', 'increased circulating valine level', 0.4056603773584906, 10.437222266468963, 2.057660691948563, 'UPHENO:0082543', 'increased bodily fluid acid level'),
(883009, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0030661', 'increased circulating arginine level', 0.41346153846153844, 10.437222266468963, 2.077351673539962, 'UPHENO:0082543', 'increased bodily fluid acid level'),
(883010, 'HP:0004923', 'Hyperphenylalaninemia', 'MP:0030670', 'increased circulating phenylalanine level', 0.5102040816326531, 16.607147267911277, 2.9108476978988262, 'UPHENO:0068312', 'increased level of phenylalanine in blood'),
(883011, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0005195', 'abnormal posterior eye segment morphology', 0.425531914893617, 7.832360208310102, 1.82562845003543, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(883012, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0006209', 'calcified intraocular region', 0.4489795918367347, 8.581084971325078, 1.962837748756089, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(883013, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0006164', 'ectropion', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(883014, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0003381', 'vitreal fibroplasia', 0.4117647058823529, 7.832360208310102, 1.7958534176094256, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(883015, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0002699', 'abnormal vitreous body morphology', 0.42, 7.832360208310102, 1.8137230459720808, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(883016, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0014087', 'retrolental blood', 0.4166666666666667, 7.832360208310102, 1.806511394962459, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(883017, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0010081', 'posterior microphthalmia', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(883018, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0005176', 'eyelids fail to open', 0.4230769230769231, 8.581084971325078, 1.9053763476882568, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(883019, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0006248', 'lagophthalmos', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(883020, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0002864', 'abnormal ocular fundus morphology', 0.40816326530612246, 7.832360208310102, 1.7879825831583462, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(883021, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0002697', 'abnormal eye size', 0.4489795918367347, 8.581084971325078, 1.962837748756089, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(883022, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0006200', 'vitreous body deposition', 0.4117647058823529, 7.832360208310102, 1.7958534176094256, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(883023, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0003671', 'abnormal eyelid aperture', 0.40384615384615385, 6.679863125803252, 1.6424484867338733, 'UPHENO:0087924', 'abnormal camera-type eye morphology'),
(883024, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0031290', 'bilateral microphthalmia', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(883025, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0001297', 'microphthalmia', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(883026, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0001296', 'macrophthalmia', 0.41509433962264153, 8.581084971325078, 1.887315500762381, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(883027, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0001289', 'persistence of hyaloid vascular system', 0.40384615384615385, 7.832360208310102, 1.7785017699354968, 'UPHENO:0087596', 'abnormal posterior segment of eyeball morphology'),
(883028, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0009274', 'buphthalmos', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(883029, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0006225', 'ocular rupture', 0.4489795918367347, 8.581084971325078, 1.962837748756089, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(883030, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0031289', 'unilateral microphthalmia', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(883031, 'HP:0030611', 'Retinal pigment epithelial loss on macular OCT', 'MP:0006249', 'phthisis bulbi', 0.4074074074074074, 8.581084971325078, 1.8697586959044252, 'UPHENO:0021474', 'abnormal camera-type eye morphology'),
(883032, 'HP:3000018', 'Abnormality of zygomaticus major muscle', 'MP:0030185', 'abnormal minor zygomaticus muscle morphology', 0.40384615384615385, 11.78271883249473, 2.1813770151795495, 'UPHENO:0087116', 'abnormal cheek morphology'),
(883033, 'HP:3000018', 'Abnormality of zygomaticus major muscle', 'MP:0030186', 'abnormal major zygomaticus muscle morphology', 0.40384615384615385, 11.78271883249473, 2.1813770151795495, 'UPHENO:0087116', 'abnormal cheek morphology'),
(883034, 'HP:3000018', 'Abnormality of zygomaticus major muscle', 'MP:0030184', 'abnormal zygomaticus muscle morphology', 0.4117647058823529, 11.78271883249473, 2.202659246128791, 'UPHENO:0087116', 'abnormal cheek morphology'),
(883035, 'HP:3000018', 'Abnormality of zygomaticus major muscle', 'MP:0030246', 'abnormal cheek morphology', 0.4090909090909091, 11.78271883249473, 2.1954961076594612, 'UPHENO:0087116', 'abnormal cheek morphology'),
(883036, 'HP:3000018', 'Abnormality of zygomaticus major muscle', 'MP:0030151', 'abnormal buccinator muscle morphology', 0.4117647058823529, 11.78271883249473, 2.202659246128791, 'UPHENO:0087116', 'abnormal cheek morphology'),
(883037, 'HP:0012606', 'Renal sodium wasting', 'MP:0011434', 'abnormal urine magnesium level', 0.4166666666666667, 9.150450616995217, 1.9526104980464847, 'UPHENO:0081544', 'abnormal role urine level'),
(883038, 'HP:0012606', 'Renal sodium wasting', 'MP:0030777', 'abnormal urine citrate level', 0.4375, 9.150450616995217, 2.0008303638578178, 'UPHENO:0081544', 'abnormal role urine level'),
(883039, 'HP:0012606', 'Renal sodium wasting', 'MP:0006317', 'decreased urine sodium level', 0.46153846153846156, 14.87018167374507, 2.6197634955273585, 'UPHENO:0051887', 'abnormal urine sodium atom level'),
(883040, 'HP:0012606', 'Renal sodium wasting', 'MP:0030782', 'abnormal urine glycerol level', 0.42, 9.150450616995217, 1.9604053813275435, 'UPHENO:0081544', 'abnormal role urine level'),
(883041, 'HP:0012606', 'Renal sodium wasting', 'MP:0011478', 'abnormal urine catecholamine level', 0.425531914893617, 9.150450616995217, 1.9732736184293993, 'UPHENO:0081544', 'abnormal role urine level'),
(883042, 'HP:0012606', 'Renal sodium wasting', 'MP:0006274', 'abnormal urine sodium level', 0.5333333333333333, 14.87018167374507, 2.8161611387366854, 'UPHENO:0051887', 'abnormal urine sodium atom level'),
(883043, 'HP:0012606', 'Renal sodium wasting', 'MP:0006315', 'abnormal urine protein level', 0.4166666666666667, 9.150450616995217, 1.9526104980464847, 'UPHENO:0081544', 'abnormal role urine level'),
(883044, 'HP:0012606', 'Renal sodium wasting', 'MP:0011461', 'abnormal urine bicarbonate level', 0.4117647058823529, 9.150450616995217, 1.9410905715597173, 'UPHENO:0081544', 'abnormal role urine level'),
(883045, 'HP:0012606', 'Renal sodium wasting', 'MP:0009471', 'abnormal urine sulfate level', 0.42857142857142855, 9.150450616995217, 1.980308484301865, 'UPHENO:0081544', 'abnormal role urine level'),
(883046, 'HP:0012606', 'Renal sodium wasting', 'MP:0011742', 'decreased urine nitrite level', 0.40384615384615385, 9.150450616995217, 1.9223356334502786, 'UPHENO:0081544', 'abnormal role urine level'),
(883047, 'HP:0012606', 'Renal sodium wasting', 'MP:0009809', 'abnormal urine uric acid level', 0.4666666666666667, 9.150450616995217, 2.066448714081988, 'UPHENO:0081544', 'abnormal role urine level'),
(883048, 'HP:0012606', 'Renal sodium wasting', 'MP:0011740', 'abnormal urine nitrite level', 0.4666666666666667, 9.150450616995217, 2.066448714081988, 'UPHENO:0081544', 'abnormal role urine level'),
(883049, 'HP:0012606', 'Renal sodium wasting', 'MP:0004820', 'abnormal urine potassium level', 0.4375, 9.150450616995217, 2.0008303638578178, 'UPHENO:0081544', 'abnormal role urine level'),
(883050, 'HP:0012606', 'Renal sodium wasting', 'MP:0006316', 'increased urine sodium level', 0.46153846153846156, 14.87018167374507, 2.6197634955273585, 'UPHENO:0051887', 'abnormal urine sodium atom level'),
(883051, 'HP:0012606', 'Renal sodium wasting', 'MP:0011734', 'abnormal urine ammonia level', 0.45652173913043476, 9.150450616995217, 2.0438638970092446, 'UPHENO:0081544', 'abnormal role urine level'),
(883052, 'HP:0012606', 'Renal sodium wasting', 'MP:0011458', 'abnormal urine chloride ion level', 0.4375, 9.150450616995217, 2.0008303638578178, 'UPHENO:0081544', 'abnormal role urine level'),
(883053, 'HP:0012606', 'Renal sodium wasting', 'MP:0001758', 'abnormal urine glucose level', 0.45652173913043476, 9.150450616995217, 2.0438638970092446, 'UPHENO:0081544', 'abnormal role urine level'),
(883054, 'HP:0012606', 'Renal sodium wasting', 'MP:0011469', 'abnormal urine creatinine level', 0.40384615384615385, 9.150450616995217, 1.9223356334502786, 'UPHENO:0081544', 'abnormal role urine level'),
(883055, 'HP:0012606', 'Renal sodium wasting', 'MP:0020153', 'abnormal urine albumin level', 0.40816326530612246, 9.150450616995217, 1.9325831942907894, 'UPHENO:0081544', 'abnormal role urine level'),
(883056, 'HP:0012606', 'Renal sodium wasting', 'MP:0011468', 'abnormal urine amino acid level', 0.40816326530612246, 9.150450616995217, 1.9325831942907894, 'UPHENO:0081544', 'abnormal role urine level'),
(883057, 'HP:0012606', 'Renal sodium wasting', 'MP:0011424', 'decreased urine uric acid level', 0.40384615384615385, 9.150450616995217, 1.9223356334502786, 'UPHENO:0081544', 'abnormal role urine level'),
(883058, 'HP:0012606', 'Renal sodium wasting', 'MP:0011552', 'abnormal urine deoxycorticosterone level', 0.4117647058823529, 9.150450616995217, 1.9410905715597173, 'UPHENO:0081544', 'abnormal role urine level'),
(883059, 'HP:0012606', 'Renal sodium wasting', 'MP:0020990', 'abnormal urine HAVCR1 level', 0.40816326530612246, 9.150450616995217, 1.9325831942907894, 'UPHENO:0081544', 'abnormal role urine level'),
(883060, 'HP:0030769', 'Exencephaly', 'MP:0012509', 'neural tube degeneration', 0.41304347826086957, 11.749166272783704, 2.2029336131567554, 'UPHENO:0020641', 'abnormal neural tube morphology'),
(883061, 'HP:0007994', 'Peripheral visual field loss', 'MP:0020219', 'increased tear production', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(883062, 'HP:0007994', 'Peripheral visual field loss', 'MP:0013145', 'eye discharge', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(883063, 'HP:0007994', 'Peripheral visual field loss', 'MP:0011831', 'abnormal visual contrast sensitivity', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(883064, 'HP:0007994', 'Peripheral visual field loss', 'MP:0006190', 'retina ischemia', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(883065, 'HP:0007994', 'Peripheral visual field loss', 'MP:0005551', 'abnormal eye electrophysiology', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(883066, 'HP:0007994', 'Peripheral visual field loss', 'MP:0008145', 'hemeralopia', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(883067, 'HP:0007994', 'Peripheral visual field loss', 'MP:0020425', 'abnormal retinal bipolar cell electrophysiology', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(883068, 'HP:0007994', 'Peripheral visual field loss', 'MP:0001337', 'dry eyes', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(883069, 'HP:0007994', 'Peripheral visual field loss', 'MP:0003011', 'delayed dark adaptation', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(883070, 'HP:0007994', 'Peripheral visual field loss', 'MP:0012032', 'abnormal ERG latency', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(883071, 'HP:0007994', 'Peripheral visual field loss', 'MP:0005257', 'abnormal intraocular pressure', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(883072, 'HP:0007994', 'Peripheral visual field loss', 'MP:0004021', 'abnormal rod electrophysiology', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(883073, 'HP:0007994', 'Peripheral visual field loss', 'MP:0005253', 'abnormal eye physiology', 0.425, 8.795504987450572, 1.9334139804155999, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(883074, 'HP:0007994', 'Peripheral visual field loss', 'MP:0003096', 'increased corneal light-scattering', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(883075, 'HP:0007994', 'Peripheral visual field loss', 'MP:0011832', 'abnormal visual acuity', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(883076, 'HP:0007994', 'Peripheral visual field loss', 'MP:0006150', 'double vision', 0.40476190476190477, 8.795504987450572, 1.8868188445272978, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
(883077, 'HP:0007994', 'Peripheral visual field loss', 'MP:0014132', 'abnormal tear film physiology', 0.4146341463414634, 8.795504987450572, 1.9096902110325777, 'UPHENO:0002219', 'abnormality of camera-type eye physiology'),
